{"content":"<li class=\"n-box-item date-title\" data-end=\"1543381199\" data-start=\"1543294800\" data-txt=\"Monday, December 23, 2019\">Tuesday, November 27, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3412628\" data-ts=\"1543372044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIR\" target=\"_blank\">HAIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412628-restoration-robotics-files-for-100m-mixed-shelf-offering-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restoration Robotics files for $100M mixed shelf offering; shares down 5% after hours</a></h4><ul>\n<li>Restoration Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1409269/000119312518335363/d660640ds3.htm\" target=\"_blank\">prospectus </a>for a $100M mixed shelf offering.</li>\n<li>Shares are down <font color=\"red\">5%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412628\" data-linked=\"Restoration Robotics files for $100M mixed shelf offering; shares down 5% after hours\" data-tweet=\"$HAIR $VERO - Restoration Robotics files for $100M mixed shelf offering; shares down 5% after hours https://seekingalpha.com/news/3412628-restoration-robotics-files-for-100m-mixed-shelf-offering-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3412628-restoration-robotics-files-for-100m-mixed-shelf-offering-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412625\" data-ts=\"1543371592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCKT\" target=\"_blank\">RCKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412625-rocket-pharma-prices-stock-offering-15_50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rocket Pharma prices stock offering at $15.50</a></h4><ul>\n<li>Rocket Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RCKT' title='Rocket Pharmaceuticals, Inc.'>RCKT</a>) <a href=\"https://seekingalpha.com/pr/17343166-rocket-pharmaceuticals-prices-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 3.55M common shares at $15.50 per share. Underwriters over-allotment is an additional 532.5K shares. Closing date is November 30.</li>\n<li>Today's close was $16.35.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412625\" data-linked=\"Rocket Pharma prices stock offering at $15.50\" data-tweet=\"$RCKT - Rocket Pharma prices stock offering at $15.50 https://seekingalpha.com/news/3412625-rocket-pharma-prices-stock-offering-15_50?source=tweet\" data-url=\"https://seekingalpha.com/news/3412625-rocket-pharma-prices-stock-offering-15_50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412622\" data-ts=\"1543364846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDS\" target=\"_blank\">PDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412622-ensign-energy-wins-bid-for-trinidad-drilling-precision-seeks-20m-breakup-fee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ensign Energy wins bid for Trinidad Drilling; Precision seeks $20M breakup fee</a></h4><ul>\n<li>Precision Drilling (NYSE:<a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a>) <font color=\"green\">+4%</font> after-hours as it <a href=\"https://globenewswire.com/news-release/2018/11/27/1657795/0/en/Precision-Drilling-Terminates-Arrangement-Agreement-With-Trinidad-Drilling-Requiring-Payment-of-Termination-Fee-Following-Ensign-Take-Up.html\" target=\"_blank\">terminates its agreement</a> to buy Trinidad Drilling (<a href='https://seekingalpha.com/symbol/TDGCF' title='Trinidad Drilling Ltd.'>OTCPK:TDGCF</a>) following an announcement by Ensign Energy Services (<a href='https://seekingalpha.com/symbol/ESVIF' title='Ensign Energy Services Inc.'>OTCPK:ESVIF</a>) that 56% of Trinidad shareholders supported its unsolicited all-cash offer for the company.</li>\n<li>Ensign made a hostile offer for control of Trinidad in August, offering $1.68/share in a deal valued at $947M, then last month PDS and Trinidad jointly announced an all-share deal valued at ~$1B, but a sharp slide in PDS shares caused the value of its offer to slip below  Ensign\u2019s cash offer, which ultimately prevailed.</li>\n<li>PDS says Trinidad now owes it a $20M termination fee, setting up a <a href=\"https://business.financialpost.com/commodities/energy/precision-demands-20m-in-break-fee-from-trinidad-drilling-as-rival-ensigns-hostile-bid-prevails\" target=\"_blank\">potential new fight</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412622\" data-linked=\"Ensign Energy wins bid for Trinidad Drilling; Precision seeks $20M breakup fee\" data-tweet=\"$PDS $PDS $TDGCF - Ensign Energy wins bid for Trinidad Drilling; Precision seeks $20M breakup fee https://seekingalpha.com/news/3412622-ensign-energy-wins-bid-for-trinidad-drilling-precision-seeks-20m-breakup-fee?source=tweet\" data-url=\"https://seekingalpha.com/news/3412622-ensign-energy-wins-bid-for-trinidad-drilling-precision-seeks-20m-breakup-fee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412621\" data-ts=\"1543363966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFSI\" target=\"_blank\">AFSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412621-amtrust-says-going-private-deal-gets-regulatory-ok\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmTrust says going-private deal gets regulatory OK</a></h4><ul>\n<li>AmTrust Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a>) <font color=\"green\">+5.1%</font> after-hours following news that it <a href=\"https://seekingalpha.com/pr/17343101-amtrust-go-private-transaction-receives-regulatory-approval\" target=\"_blank\">received all regulatory approvals</a> for its go-private deal, which is now expected to close on Nov. 29.</li>\n<li>Evergreen Parent LP will acquire the ~45% of AFSI\u2019s issued and outstanding common shares  that the Karfunkel and Zyskind families and affiliated parties do not already own or control.</li>\n<li>At closing, AFSI shareholders will receive $14.75 for each common share they own.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412621\" data-linked=\"AmTrust says going-private deal gets regulatory OK\" data-tweet=\"$AFSI - AmTrust says going-private deal gets regulatory OK https://seekingalpha.com/news/3412621-amtrust-says-going-private-deal-gets-regulatory-ok?source=tweet\" data-url=\"https://seekingalpha.com/news/3412621-amtrust-says-going-private-deal-gets-regulatory-ok\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>208&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412610\" data-ts=\"1543358262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412610-crm-gwph-and-ntnx-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRM, GWPH and NTNX among after hour movers</a></h4><ul>\n<li>\n<strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color=\"green\">+8.4%</font>. <a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a> <font color=\"green\">+7.5%</font>. <a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a> <font color=\"green\">+5.1%</font>. <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color=\"green\">+4.7%</font>. <a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a> <font color=\"green\">+4.4%</font>.<strong></strong>\n</li>\n<li>\n<strong>Losers: </strong><a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color=\"red\">-4.4%</font>. <a href='https://seekingalpha.com/symbol/GNL' title='Global Net Lease, Inc.'>GNL</a> <font color=\"red\">-4.3%</font>. <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color=\"red\">-4.0%</font>.<a href='https://seekingalpha.com/symbol/JAX' title='J. Alexander&#39;s Holdings, Inc.'>JAX</a> <font color=\"red\">-3.5%</font>. <a href='https://seekingalpha.com/symbol/SIGA' title='SIGA Technologies Inc.'>SIGA</a> <font color=\"red\">-3.3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412610\" data-linked=\"CRM, GWPH and NTNX among after hour movers\" data-tweet=\"$NTNX $NTNX $CRM - CRM, GWPH and NTNX among after hour movers https://seekingalpha.com/news/3412610-crm-gwph-and-ntnx-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3412610-crm-gwph-and-ntnx-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412607\" data-ts=\"1543357512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMD\" target=\"_blank\">CRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412607-cormedix-rebounds-4_2-insider-buys-disclosed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CorMedix rebounds 4.2% with insider buys disclosed</a></h4><ul>   <li>CorMedix (NYSEMKT:<a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a>) is <font color=\"green\">4.2% higher</font> after hours, rebounding somewhat from a <font color=\"red\">decline of 7.7%</font> today amid some insider buys freshly disclosed.</li>    <li>Director Myron Kaplan <a href=\"https://seekingalpha.com/filing/4250074\" target=\"_blank\">bought 50,000 shares</a> on Friday at an average price of $1.2959, leaving him with 371,166 shares.</li>    <li>Meanwhile, CEO Khoso Baluch <a href=\"https://seekingalpha.com/filing/4250324\" target=\"_blank\">bought 3,500 shares yesterday</a> at $1.28 each, and another 21,500 shares today at $1.21, leaving his holdings at 250,373 shares.</li>    <li>And Chief Financial Officer Robert Cook <a href=\"https://seekingalpha.com/filing/4250310\" target=\"_blank\">bought 25,000 shares today</a> at $1.1685, leaving his holdings at 127,083 shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412607\" data-linked=\"CorMedix rebounds 4.2% with insider buys disclosed\" data-tweet=\"$CRMD - CorMedix rebounds 4.2% with insider buys disclosed https://seekingalpha.com/news/3412607-cormedix-rebounds-4_2-insider-buys-disclosed?source=tweet\" data-url=\"https://seekingalpha.com/news/3412607-cormedix-rebounds-4_2-insider-buys-disclosed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412600\" data-ts=\"1543356275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412600-yy-dips-cautious-jpmorgan-trims-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY dips as cautious JPMorgan trims to Neutral</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color=\"red\">1.5% lower</font> after hours following a downgrade to Neutral from Overweight by a \"cautious\" JPMorgan.</li>    <li>YY Live revenue growth that has been 30% in 2017 and 17% in 2018 should slow to 5% in 2019, amid the lack of new game features and macro headwinds hitting YY's top spenders. The firm's looking for a new catalyst and thinks Bigo consolidation might serve in the next six to 12 months. (h/t Bloomberg)</li>    <li>JPMorgan cut its price target to $70 from $85, implying just 2.9% upside from today's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412600\" data-linked=\"YY dips as cautious JPMorgan trims to Neutral\" data-tweet=\"$YY - YY dips as cautious JPMorgan trims to Neutral https://seekingalpha.com/news/3412600-yy-dips-cautious-jpmorgan-trims-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3412600-yy-dips-cautious-jpmorgan-trims-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412585\" data-ts=\"1543354659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412585-nutanixplus-10-on-q1-beats-in-line-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutanix +10% on Q1 beats, in-line guide</a></h4><ul>\n<li>Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a>) <font color=\"green\">gains 10.3%</font> after Q1 revenue and EPS beats. In-line Q2 guidance has revenue of $325M to $335M (consensus: $326.51M) and EPS of about -$0.25 (consensus: -$0.26).</li>\n<li>Revenue breakdown: Product, $224.3M (consensus: $221.8M); Support and Services, $88.9M (consensus: $83.5M).</li>\n<li>Gross margin came in at 78.6% and operating margin at -8.3% (consensus: -15.1%).</li>\n<li>\n<a href=\"https://seekingalpha.com/pr/17342952-nutanix-reports-first-quarter-fiscal-2019-financial-results\" target=\"_blank\">Press release</a>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412548-nutanix-beats-0_14-beats-revenue\" target=\"_blank\">Nutanix beats by $0.14, beats on revenue</a> (Nov. 27)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412585\" data-linked=\"Nutanix +10% on Q1 beats, in-line guide\" data-tweet=\"$NTNX - Nutanix +10% on Q1 beats, in-line guide https://seekingalpha.com/news/3412585-nutanixplus-10-on-q1-beats-in-line-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3412585-nutanixplus-10-on-q1-beats-in-line-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412580\" data-ts=\"1543354118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412580-salesforceplus-3_7-on-q3-beats-raised-fy-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce +3.7% on Q3 beats, raised FY guide</a></h4><ul>\n<li>Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) <font color=\"green\">gains 3.7%</font> aftermarket after reporting Q3 beats with EPS of $0.61 and revenue of $3.39B (+26%). Q4 guidance has in-line revenue of $3.551B to $3.561B (consensus: $3.53B) and downside EPS of $0.54 to $0.55 (consensus: $0.57).</li>\n<li>Revenue breakdown: Subscription, $3.17B (consensus: $3.14B); Services, $224M (consensus: $228.1M).</li>\n<li>Raised FY19 guidance has EPS from $2.60 to $2.61 (prior guidance: $2.50 - $2.52) and revenue from $13.23B to $13.24B (prior: $13.125B - $13.175B).</li>\n<li>Upside FY20 guidance has revenue from $15.9B to $16B (consensus: $15.83B).</li>\n<li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://investor.salesforce.com/about-us/investor/overview/default.aspx\" target=\"_blank\">here</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/pr/17342979-salesforce-announces-record-third-quarter-fiscal-2019-results\" target=\"_blank\">Press release</a>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412557-salesforce-com-beats-0_11-beats-revenue\" target=\"_blank\">Salesforce.com beats by $0.11, beats on revenue</a> (Nov. 27)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412580\" data-linked=\"Salesforce +3.7% on Q3 beats, raised FY guide\" data-tweet=\"$CRM - Salesforce +3.7% on Q3 beats, raised FY guide https://seekingalpha.com/news/3412580-salesforceplus-3_7-on-q3-beats-raised-fy-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3412580-salesforceplus-3_7-on-q3-beats-raised-fy-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412576\" data-ts=\"1543353783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TS\" target=\"_blank\">TS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412576-tenarisminus-10-after-chairman-charged-in-graft-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenaris -10% after chairman charged in graft case</a></h4><ul>\n<li>Tenaris (<a href='https://seekingalpha.com/symbol/TS' title='Tenaris S.A.'>TS</a> <font color='red'>-9.8%</font>) turned sharply lower in the afternoon following reports that the Argentine judge overseeing an investigation into the so-called notebook scandal has charged Chairman and majority shareholder Paolo Rocca as <a href=\"https://finance.yahoo.com/news/tenaris-shares-plunge-billionaire-chairman-202128272.html\" target=\"_blank\">part of a graft case</a>.</li>\n<li>The judge set a $103M bond and forbade Rocca from leaving the country.</li>\n<li>The move comes as the judge probes hundreds of alleged bribes paid by construction companies, energy suppliers and electricity generators to members of the former government.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412576\" data-linked=\"Tenaris -10% after chairman charged in graft case\" data-tweet=\"$TS - Tenaris -10% after chairman charged in graft case https://seekingalpha.com/news/3412576-tenarisminus-10-after-chairman-charged-in-graft-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3412576-tenarisminus-10-after-chairman-charged-in-graft-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412574\" data-ts=\"1543353691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNL\" target=\"_blank\">GNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412574-global-net-leaseminus-3_5-after-announcing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Net Lease -3.5% after announcing stock offering</a></h4><ul>\n<li>Global Net Lease (NYSE:<a href='https://seekingalpha.com/symbol/GNL' title='Global Net Lease, Inc.'>GNL</a>) <font color=\"red\">sinks 3.5%</font> in after-hours trading after announcing the launch of a 4M-share public stock offering.</li>\n<li>Greenshoe option for an additional 600,000 shares.</li>\n<li>GNL intends to use the net proceeds from the offering to fund acquisitions, as well as for general corporate purposes.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3406502-global-net-lease-q3-results-noi-increases-16-percent-y-y\" target=\"_blank\">More on Global Net Lease Q3 results: NOI increases 16% Y/Y</a> (Nov. 7)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412574\" data-linked=\"Global Net Lease -3.5% after announcing stock offering\" data-tweet=\"$GNL - Global Net Lease -3.5% after announcing stock offering https://seekingalpha.com/news/3412574-global-net-leaseminus-3_5-after-announcing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3412574-global-net-leaseminus-3_5-after-announcing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412571\" data-ts=\"1543353506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412571-gw-pharma-fq4-topline-down-1-fy-cash-flow-down-56\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma FQ4 topline down 1%; FY cash flow down 56%</a></h4><ul>\n<li>GW Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>) <a href=\"https://seekingalpha.com/pr/17342942-gw-pharmaceuticals-plc-reports-fiscal-fourth-quarter-year-end-2018-financial-results\" target=\"_blank\">fiscal Q4 results</a> ($M): Revenues: 2.4 (-1.2%); product sales: 2.3 (-1.1%).</li>\n<li>Net loss: (79.9) (-48.2%); loss/share: (0.23) (-27.8%); cash flow ops &#40;FY&#41;: (231.9) (-55.6%).</li>\n<li>Meeting with FDA next month to clarify regulatory path for Sativex for multiple sclerosis spasticity.</li>\n<li>Open-label study of CBDV in Rett syndrome to start next quarter.</li>\n<li>Phase 2 study of IV CBD in neonatal hypoxic-ischemic encephalopathy to start in H1 2019.</li>\n<li>Shares are up a fraction after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412571\" data-linked=\"GW Pharma FQ4 topline down 1%; FY cash flow down 56%\" data-tweet=\"$GWPH - GW Pharma FQ4 topline down 1%; FY cash flow down 56% https://seekingalpha.com/news/3412571-gw-pharma-fq4-topline-down-1-fy-cash-flow-down-56?source=tweet\" data-url=\"https://seekingalpha.com/news/3412571-gw-pharma-fq4-topline-down-1-fy-cash-flow-down-56\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412548\" data-ts=\"1543352656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412548-nutanix-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutanix beats by $0.14, beats on revenue</a></h4><ul>\n<li>Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a>): Q1 Non-GAAP EPS of -$0.13 <span style=\"color:green\">beats by $0.14</span>; GAAP EPS of -$0.54 <span style=\"color:red\">misses by $0.01</span>.</li>\n<li>Revenue of $313.28M (+13.7% Y/Y) <font color=\"green\">beats by $8.07M</font>.</li>\n<li>Shares <font color=\"green\">+2.5%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17342952-nutanix-reports-first-quarter-fiscal-2019-financial-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412548\" data-linked=\"Nutanix beats by $0.14, beats on revenue\" data-tweet=\"$NTNX - Nutanix beats by $0.14, beats on revenue https://seekingalpha.com/news/3412548-nutanix-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3412548-nutanix-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412540\" data-ts=\"1543351094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412540-jinkosolar-lifts-peers-for-second-straight-day-after-better-expected-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar lifts peers for second straight day after better than expected Q3</a></h4><ul>\n<li>JinkoSolar (<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='green'>+10.1%</font>) has surged 27% in two days following <a href=\"https://seekingalpha.com/news/3412044-jinkosolar-plus-13-percent-pv-module-shipments-hit-quarterly-record\" target=\"_blank\">stronger than expected Q3 results</a> that included a <a href=\"https://www.pv-tech.org/news/jinkosolar-slowing-down-manufacturing-capacity-expansions\" target=\"_blank\">slowdown</a> in planned manufacturing capacity expansions.</li>\n<li>JKS says it expects a  recovery in the China market next year (55-plus GW) as well as growing  demand across major markets such as India, U.S. and Europe.</li>\n<li>China earlier this year cut a key incentive for domestic solar development, weighing on JKS and its competitors, but the pullback may have been <a href=\"https://finance.yahoo.com/news/solar-panel-makers-rise-jinko-183214206.html\" target=\"_blank\">less severe than expected</a>; JKS says developers installed 34.5 GW gigawatts in China through September, and the company shipped a record 2.95 GW in Q3 with expectations to ship as much as 4 GW in Q4.</li>\n<li>Other solar names also are taking off in today's trade: <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color=\"green\">+9.7%</font>, <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color=\"green\">+7.7%</font>, <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color=\"green\">+6.3%</font>, <a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color=\"green\">+3.2%</font>, <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color=\"green\">+1.9%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412540\" data-linked=\"JinkoSolar lifts peers for second straight day after better than expected Q3\" data-tweet=\"$JKS $JKS $VSLR - JinkoSolar lifts peers for second straight day after better than expected Q3 https://seekingalpha.com/news/3412540-jinkosolar-lifts-peers-for-second-straight-day-after-better-expected-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3412540-jinkosolar-lifts-peers-for-second-straight-day-after-better-expected-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412538\" data-ts=\"1543350835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412538-therapix-bio-down-16-on-convertible-debt-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Bio down 16% on convertible debt deal</a></h4><ul> <li>Thinly traded nano cap Therapix Biosciences (<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color=\"red\">-15.9%</font>) is down on below-average volume on the heels of its $2.5M convertible debt <a href=\"https://seekingalpha.com/pr/17342086-therapix-biosciences-issues-1500-000-convertible-debenture\" target=\"_blank\">placement </a>with a fund managed by Yorkville Advisors Global.</li> <li>The debentures will accrue 5% interest per annum. The first trance of $1.5M was issued on November 23. The remaining tranches of $500K each will be issued after a period of time or in response to certain events. They are convertible at the lower of $7.00 or 95% of the lowest volume-weighted average price during the five consecutive trading days prior to the conversion date.</li> <li>The investor will receive 9,171 ADSs as a commitment fee.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412538\" data-linked=\"Therapix Bio down 16% on convertible debt deal\" data-tweet=\"$TRPX - Therapix Bio down 16% on convertible debt deal https://seekingalpha.com/news/3412538-therapix-bio-down-16-on-convertible-debt-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3412538-therapix-bio-down-16-on-convertible-debt-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412535\" data-ts=\"1543350199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412535-catalyst-pharma-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma shares halted pending news</a></h4><ul> <li>Nasdaq has suspended trading in Catalyst Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color=\"red\">-0.3%</font>) pending the release of news, a near-certainty that it pertains to the potential FDA approval of Firdapse for Lambert-Eaton myasthenic syndrome &#40;LEMS&#41;. The agency's action date under accelerated review is tomorrow.</li> <li>\n<strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17342994-catalyst-pharmaceuticals-announces-firdapse-amifampridine-new-drug-application-continues\" target=\"_blank\">statement</a>, the company says it has not received word from the FDA on the status of its marketing application. Apparently, a contractor working on a web page allowed a screen to be viewed that implied it had received the FDA response.</li>\n<li>\n<strong>Update</strong>: Shares will resume trading at 4:45 pm ET.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412535\" data-linked=\"Catalyst Pharma shares halted pending news\" data-tweet=\"$CPRX - Catalyst Pharma shares halted pending news https://seekingalpha.com/news/3412535-catalyst-pharma-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3412535-catalyst-pharma-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412532\" data-ts=\"1543349943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412532-thr-youtube-pulling-back-from-scripted-content-spending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">THR: YouTube pulling back from scripted content spending</a></h4><ul>   <li>YouTube (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color=\"red\">-0.6%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color=\"red\">-0.6%</font>) is <a href=\"https://www.hollywoodreporter.com/live-feed/youtube-pull-back-scripted-programming-ad-supported-push-1164256?utm_source=twitter\" target=\"_blank\">pulling back from scripted content output</a>, a reversal of a strategy that pushed a premium subscription tier, <i>The Hollywood Reporter</i> says.</li>    <li>The video platform will cut back starting in 2020, and executive will double down on the ad-supported video by making all its originals free to all users, not just those paying $12/month for YouTube Premium.</li>    <li>That means a \"serious budget reduction,\" if not a total pullback from what has been hot competition among distributors for bigger-budget content.</li>    <li>The platform might release a show week-to-week for free while giving Premium subscriber the option to binge.</li>    <li>YouTube's originals budget (said to be hundreds of millions of dollars a year) is still overshadowed by the billions annually at Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color=\"green\">+1.7%</font>) and Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color=\"red\">-0.1%</font>).</li>    <li>Also a player here: Hulu, co-owned by Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"green\">+1.6%</font>), Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color=\"green\">+1.3%</font>), Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color=\"green\">+0.6%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color=\"green\">+0.5%</font>) and WarnerMedia (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+1.5%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412532\" data-linked=\"THR: YouTube pulling back from scripted content spending\" data-tweet=\"$GOOG $GOOG $GOOGL - THR: YouTube pulling back from scripted content spending https://seekingalpha.com/news/3412532-thr-youtube-pulling-back-from-scripted-content-spending?source=tweet\" data-url=\"https://seekingalpha.com/news/3412532-thr-youtube-pulling-back-from-scripted-content-spending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412530\" data-ts=\"1543349935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTI\" target=\"_blank\">PTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412530-positive-data-from-vertex-pressures-proteostasis-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive data from Vertex pressures Proteostasis, down 9%</a></h4><ul> <li>Proteostasis Therapeutics (<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color=\"red\">-8.7%</font>) is down on below-average volume in apparent reaction to positive late-stage data on Vertex Pharmaceuticals' cystic fibrosis &#40;CF&#41; triplet therapy that includes a next-generation corrector.</li> <li>PTI is developing its own <a href=\"https://seekingalpha.com/news/3398229-proteostasis-32-percent-hours-positive-early-stage-data-cf-candidates\" target=\"_blank\">triplet therapy</a> for CF. Preliminary Phase 1 data should be available this quarter.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3412358-vertex-pharmas-triplet-therapy-cf-successful-two-late-stage-studies\" target=\"_blank\">Vertex Pharma's triplet therapy for CF successful in two late-stage studies</a> (Nov. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412530\" data-linked=\"Positive data from Vertex pressures Proteostasis, down 9%\" data-tweet=\"$PTI - Positive data from Vertex pressures Proteostasis, down 9% https://seekingalpha.com/news/3412530-positive-data-from-vertex-pressures-proteostasis-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3412530-positive-data-from-vertex-pressures-proteostasis-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412529\" data-ts=\"1543349886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412529-agfa-gevaert-chooses-verizon-for-global-network-transformation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agfa-Gevaert chooses Verizon for global network transformation</a></h4><ul>   <li>Agfa-Gevaert is going with Verizon Enterprise Solutions (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color=\"green\">+2.2%</font>) for a global <a href=\"https://seekingalpha.com/pr/17342785-agfa-chooses-verizon-enterprise-solutions-global-network-transformation\" target=\"_blank\">network transformation initiative</a>.</li>    <li>Verizon's managed network services and software-defined networking will take over net management from Agfa, letting the imaging/IT conglomerate focus on service and solution delivery.</li>    <li>Agfa is a longtime Verizon customer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412529\" data-linked=\"Agfa-Gevaert chooses Verizon for global network transformation\" data-tweet=\"$VZ - Agfa-Gevaert chooses Verizon for global network transformation https://seekingalpha.com/news/3412529-agfa-gevaert-chooses-verizon-for-global-network-transformation?source=tweet\" data-url=\"https://seekingalpha.com/news/3412529-agfa-gevaert-chooses-verizon-for-global-network-transformation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412525\" data-ts=\"1543349307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRI\" target=\"_blank\">CRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412525-carters-moves-higher-after-gymboree-store-cut-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carter&#39;s moves higher after Gymboree store cut report</a></h4><ul>\n<li>Carter's (<a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a> <font color='red'>-1.2%</font>) is off its session low after Reuters reports that Gymboree is considering cutting its store base in half.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412522-gymboree-eyes-closing-half-stores\" target=\"_blank\">Gymboree eyes closing half its stores</a> (Nov. 27)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412525\" data-linked=\"Carter&#39;s moves higher after Gymboree store cut report\" data-tweet=\"$CRI - Carter&#39;s moves higher after Gymboree store cut report https://seekingalpha.com/news/3412525-carters-moves-higher-after-gymboree-store-cut-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3412525-carters-moves-higher-after-gymboree-store-cut-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412523\" data-ts=\"1543348838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEMD\" target=\"_blank\">AEMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412523-technology-top-5-gainers-losers-of-3_00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM</a></h4><ul>\n<li>\n<strong>Gainers: </strong>Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) <font color=\"green\">+35%</font>. Daqo New Energy (NYSE:<a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a>) <font color=\"green\">+13%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"green\">+12%</font>. AXT (NASDAQ:<a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a>) <font color=\"green\">+11%</font>. JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"green\">+11%</font>.</li> <li>\n<strong>Losers: </strong>Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) <font color=\"red\">-31%</font>. Cubic Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a>) <font color=\"red\">-11%</font>. NantHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a>) <font color=\"red\">-11%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"red\">-10%</font>. Diebold Nixdorf (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412523\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM\" data-tweet=\"$AEMD $AEMD $DQ - Technology - Top 5 Gainers / Losers as of 3.00 PM https://seekingalpha.com/news/3412523-technology-top-5-gainers-losers-of-3_00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3412523-technology-top-5-gainers-losers-of-3_00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412521\" data-ts=\"1543348243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FANG\" target=\"_blank\">FANG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412521-diamondback-energy-energen-shareholders-approve-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diamondback Energy, Energen shareholders approve merger</a></h4><ul> <li>Diamondback Energy (<a href='https://seekingalpha.com/symbol/FANG' title='Diamondback Energy'>FANG</a> <font color=\"green\">+1.1%</font>) and Energen (<a href='https://seekingalpha.com/symbol/EGN' title='Energen Corporation'>EGN</a> <font color=\"green\">+1.4%</font>) say all proposals necessary for their pending merger were <a href=\"https://seekingalpha.com/pr/17342845-stockholders-diamondback-energy-inc-shareholders-energen-corporation-approve-merger\" target=\"_blank\">approved</a> by the respective shareholders of each company at special meetings today, clearing the way for the deal to close by Nov. 29.</li> <li>Under the deal terms, each eligible EGN common share will be converted into the right to receive 0.6442 of a share of FANG common stock.</li> <li>The <a href=\"https://seekingalpha.com/news/3382757-diamondback-energy-buy-energen-stock-deal-worth-9_2b\" target=\"_blank\">combined company</a> will own more than 266K net tier one acres in the Permian Basin, an increase of 57% from FANG's current tier one acreage of 170K net acres.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412521\" data-linked=\"Diamondback Energy, Energen shareholders approve merger\" data-tweet=\"$FANG $FANG $EGN - Diamondback Energy, Energen shareholders approve merger https://seekingalpha.com/news/3412521-diamondback-energy-energen-shareholders-approve-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3412521-diamondback-energy-energen-shareholders-approve-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412519\" data-ts=\"1543347096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412519-steel-stocks-in-red-steel-dynamics-new-project-to-add-to-u-s-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel stocks in the red as Steel Dynamics&#39; new project to add to U.S. supply</a></h4><ul> <li>Steel names are broadly lower following news of Steel Dynamics' (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color=\"red\">-8.2%</font>) plans to <a href=\"https://seekingalpha.com/news/3412256-steel-dynamics-build-new-organic-flat-roll-steel-mill-costing-1_7b-1_8b\" target=\"_blank\">build a new $1.7B-$1.8B electric arc furnace carbon sheet steel mill</a> in the U.S.: <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color=\"red\">-8.2%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color=\"red\">-3.8%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color=\"red\">-2.6%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color=\"red\">-1.8%</font>.</li> <li>KeyBanc analyst Philip Gibbs expected shares of U.S. carbon sheet-based companies to post losses today on the <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/11/12758476/steel-stocks-have-wall-streets-attention\" target=\"_blank\">potential for further U.S. supply growth</a>, and the prospect of more U.S. steel supply likely will weigh on steel prices.</li> <li>Also, \"STLD investors may be a bit disappointed via potential for less bandwidth to pursue full-out share buyback momentum ($729M left at September's end),\" Gibbs says.</li> <li>Longbow Research lowers its 2019 spot price outlook for hot rolled coil steel by $10 to $15/ton and now calls for 2019 prices of $790-$795/ton, a ~5% drop from 2018 average prices.</li> <li>But Longbow maintains its Buy rating and $40 price target for U.S. Steel, believing the shares are significantly undervalued even after adjusting for potential market headwinds.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412519\" data-linked=\"Steel stocks in the red as Steel Dynamics&#39; new project to add to U.S. supply\" data-tweet=\"$STLD $STLD $X - Steel stocks in the red as Steel Dynamics&#39; new project to add to U.S. supply https://seekingalpha.com/news/3412519-steel-stocks-in-red-steel-dynamics-new-project-to-add-to-u-s-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3412519-steel-stocks-in-red-steel-dynamics-new-project-to-add-to-u-s-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412518\" data-ts=\"1543346997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412518-papa-johnsminus-11-after-trian-passes-on-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s -11% after Trian passes on bid</a></h4><ul> <li>Papa John's International (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) is <font color=\"red\">down 10.5%</font> off a Wall Street Journal <a href=\"https://www.wsj.com/articles/trian-fund-management-no-longer-looking-at-papa-johns-1543346492\" target=\"_blank\">report</a> indicating that Trian Management is no longer showing an interest in the pizza chain.</li> <li>The company has been shopping itself since August, but has struggled due to the damage to the brand from ex-CEO John Schnatter and the resulting feuding.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3412518\" data-linked=\"Papa John&#39;s -11% after Trian passes on bid\" data-tweet=\"$PZZA - Papa John&#39;s -11% after Trian passes on bid https://seekingalpha.com/news/3412518-papa-johnsminus-11-after-trian-passes-on-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3412518-papa-johnsminus-11-after-trian-passes-on-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412517\" data-ts=\"1543346326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTX\" target=\"_blank\">UTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412517-united-technologiesminus-5-forecast-for-collins-division-trails-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Technologies -5% as forecast for Collins division trails estimates</a></h4><ul> <li>United Technologies (<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a> <font color=\"red\">-5.2%</font>) shares suffer their worst loss in three years after the company surprised investors with a <a href=\"https://www.bloomberg.com/news/articles/2018-11-27/united-technologies-tumbles-most-since-2015-on-cash-flow-dismay\" target=\"_blank\">weak cash flow forecast</a> from its Collins Aerospace acquisition, spoiling the debut of its long-awaited breakup plan.</li> <li>UTX says the newly formed division from the just-completed $23B purchase of Rockwell Collins will generate no more than $750M of free cash flow next year, far below the ~$1.3B average analyst forecast.</li> <li>Also, UTX says it expects the tax-free separations of Otis Elevator and Carrier to be completed in 18-24 months, slower than anticipated and adding to the pressure on the shares.</li> <li>\"The longer spin process may put United Technologies shares at risk of 'spin limbo,'\" says Barclays analyst Julian Mitchell, adding that during the period between an announcement and the close of a spinoff, the last 13 industrial stocks to go through the process have underperformed the S&amp;P 500 by 4%.</li> <li>CEO Greg Hayes said in March that one-time separation costs would probably amount to $2B-$3B with most of the expense coming from debt refinancing; in today's <a href=\"https://seekingalpha.com/article/4224827-united-technologies-corporation-utx-investor-update-call-transcript\" target=\"_blank\">conference call</a>, Hayes said the figure would total at least $2.5B.</li> <li>\n<a href=\"https://seekingalpha.com/news/3412355-united-tech-ceo-focused-business-tends-better\" target=\"_blank\">Earlier</a>: United Tech CEO: Focused business tends to do better (Nov. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412517\" data-linked=\"United Technologies -5% as forecast for Collins division trails estimates\" data-tweet=\"$UTX - United Technologies -5% as forecast for Collins division trails estimates https://seekingalpha.com/news/3412517-united-technologiesminus-5-forecast-for-collins-division-trails-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3412517-united-technologiesminus-5-forecast-for-collins-division-trails-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412508\" data-ts=\"1543345236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TREC\" target=\"_blank\">TREC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412508-ferroglobe-and-jones-energy-among-energy-materials-losers-trecora-resources-and-petrobras\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferroglobe and Jones Energy among Energy/Materials losers; Trecora Resources and  Petrobras among the gainers</a></h4><ul> <li>\n<b>Gainers: </b>Trecora Resources (NYSE:<a href='https://seekingalpha.com/symbol/TREC' title='Trecora Resources'>TREC</a>) <font color=\"green\">+9%</font>. Petrobras (NYSE:<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a>) <font color=\"green\">+6%</font>. Renewable Energy Group (NASDAQ:<a href='https://seekingalpha.com/symbol/REGI' title='Renewable Energy Group, Inc'>REGI</a>) <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers: </b>Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"red\">-60%</font>. Jones Energy (<a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a>) <font color=\"red\">-42%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-11%</font>. Mechel PAO (NYSE:<a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a>) <font color=\"red\">-10%</font>. Earthstone Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412508\" data-linked=\"Ferroglobe and Jones Energy among Energy/Materials losers; Trecora Resources and  Petrobras among the gainers\" data-tweet=\"$TREC $TREC $PBR - Ferroglobe and Jones Energy among Energy/Materials losers; Trecora Resources and Petrobras among the gainers https://seekingalpha.com/news/3412508-ferroglobe-and-jones-energy-among-energy-materials-losers-trecora-resources-and-petrobras?source=tweet\" data-url=\"https://seekingalpha.com/news/3412508-ferroglobe-and-jones-energy-among-energy-materials-losers-trecora-resources-and-petrobras\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412509\" data-ts=\"1543345226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412509-fbn-drops-proofpoint-target-on-billings-deceleration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FBN drops Proofpoint target on billings deceleration</a></h4><ul>\n<li>FBN Securities <a href=\"https://www.streetinsider.com/Analyst+Comments/Proofpoint+%28PFPT%29+PT+Lowered+to+%24105+at+FBN+Securities/14864740.html\" target=\"_blank\">maintains</a> an Outperform rating on Proofpoint (NASDAQ:<a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a>) but lowers the target by $30 to $105.</li>\n<li>The firm notes its positive channel checks showed Proofpoint would beat Q3 consensus when the company reported in late October. But the lowered price target was due to FY19 guidance below estimates and a large deceleration in current billings growth.</li>\n<li>Proofpoint shares are <font color=\"red\">down 1.3%</font> to $89.09.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3401486-proofpoint-minus-12_9-percent-q3-beats-coo-resignation\" target=\"_blank\">Proofpoint -12.9% after Q3 beats, COO resignation</a> (Oct. 25)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412509\" data-linked=\"FBN drops Proofpoint target on billings deceleration\" data-tweet=\"$PFPT - FBN drops Proofpoint target on billings deceleration https://seekingalpha.com/news/3412509-fbn-drops-proofpoint-target-on-billings-deceleration?source=tweet\" data-url=\"https://seekingalpha.com/news/3412509-fbn-drops-proofpoint-target-on-billings-deceleration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412502\" data-ts=\"1543343303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412502-stocks-pare-losses-u-s-china-trade-tensions-persist\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks pare losses as U.S.-China trade tensions persist</a></h4><ul>\n<li>Stocks are still in the red, but pare some earlier losses, as news breaks that the White House and China are holding trade talks at \"all levels\" ahead of Trump and Xi meeting.</li>\n<li>Dow<font color=\"red\"> -0.2%</font>; S&amp;P 500 <font color=\"red\">-0.2%</font>; Nasdaq <font color=\"red\">-0.3</font>%.</li>\n<li>Utilities<font color=\"green\"> +0.6%</font> is the only major sector in the green. PG&amp;E <font color=\"green\">+6.0% </font>and Edison International<font color=\"green\"> +2.3%</font> are the biggest gainers in that group.</li>\n<li>Meanwhile, industrial goods<font color=\"red\"> -1.3%</font>, conglomerates <font color=\"red\">-1.0%</font>, and basic materials <font color=\"red\">-0.9%</font>.</li>\n<li>Tech giants are still slipping: Apple <font color=\"red\">-1.1%</font>, Amazon <font color=\"red\">-0.5%</font>, Facebook <font color=\"red\">-1.6%</font>.</li>\n<li>U.S. 10-year Treasury note yield <font color=\"red\">down 1 bp</font> at 3.05%.</li>\n<li>U.S. dollar rises 0.3% against the euro.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412502\" data-linked=\"Stocks pare losses as U.S.-China trade tensions persist\" data-tweet=\"Stocks pare losses as U.S.-China trade tensions persist https://seekingalpha.com/news/3412502-stocks-pare-losses-u-s-china-trade-tensions-persist?source=tweet\" data-url=\"https://seekingalpha.com/news/3412502-stocks-pare-losses-u-s-china-trade-tensions-persist\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412499\" data-ts=\"1543342479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP\" target=\"_blank\">WPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412499-headline-wpp-considered-buying-criteo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Headline: WPP considered buying Criteo</a></h4><ul>\n<li>WPP (NYSE:<a href='https://seekingalpha.com/symbol/WPP' title='WPP Plc'>WPP</a>) <a href=\"https://www.streetinsider.com/Mergers+and+Acquisitions/WWP%2C+Plc+%28WPP%29+held+talks+to+buy+Criteo+%28CRTO%29+last+year%2C+but+talks+ended+over+valuation+-+Bloomberg/14865706.html\" target=\"_blank\">considered buying</a> Criteo (<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a> <font color='green'>+0.7%</font>) last year but had valuation concerns, according to Bloomberg sources.</li>\n<li>Headline only at the moment but will update when more information becomes available.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412499\" data-linked=\"Headline: WPP considered buying Criteo\" data-tweet=\"$WPP $WPP $CRTO - Headline: WPP considered buying Criteo https://seekingalpha.com/news/3412499-headline-wpp-considered-buying-criteo?source=tweet\" data-url=\"https://seekingalpha.com/news/3412499-headline-wpp-considered-buying-criteo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412496\" data-ts=\"1543342036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFLY\" target=\"_blank\">SFLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412496-shutterflyminus-1_5-on-cyber-monday-site-issues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shutterfly -1.5% on Cyber Monday site issues</a></h4><ul>\n<li>Shutterfly (NASDAQ:<a href='https://seekingalpha.com/symbol/SFLY' title='Shutterfly, Inc.'>SFLY</a>) <font color=\"red\">drops 1.5%</font> as KeyBanc analyst Edward Yruma comments on yesterday's technical issues that disrupted Cyber Monday.</li>\n<li>The firm notes that the issues disrupted item creation and the checkout process.</li>\n<li>The company extended its promotion but, as of this morning, the site still wasn't working properly.</li>\n<li>Source: StreetAccount.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412496\" data-linked=\"Shutterfly -1.5% on Cyber Monday site issues\" data-tweet=\"$SFLY - Shutterfly -1.5% on Cyber Monday site issues https://seekingalpha.com/news/3412496-shutterflyminus-1_5-on-cyber-monday-site-issues?source=tweet\" data-url=\"https://seekingalpha.com/news/3412496-shutterflyminus-1_5-on-cyber-monday-site-issues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412495\" data-ts=\"1543341994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABC\" target=\"_blank\">ABC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412495-drug-wholesalers-in-green-on-looming-close-of-cvs-aetna-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug wholesalers in the green on looming close of CVS/Aetna tie-up</a></h4><ul> <li>Drug distributors AmerisourceBergen (<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"green\">+0.4%</font>), McKesson (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"green\">+3.4%</font>) and Cardinal Health (<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a> <font color=\"green\">+1.5%</font>) are all up, albeit on below-average volume, as the finish line approaches for the CVS-Aetna marriage.</li> <li>The consummation of the merger should bode well for the Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-0.7%</font>) Express Scripts (<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color=\"red\">-0.2%</font>) tie-up which investors believe also creates a rosier outlook for additional deals in the pharmacy services space. UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color=\"green\">+1.1%</font>) is always in the mix as a potential suitor.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412495\" data-linked=\"Drug wholesalers in the green on looming close of CVS/Aetna tie-up\" data-tweet=\"$ABC $ABC $MCK - Drug wholesalers in the green on looming close of CVS/Aetna tie-up https://seekingalpha.com/news/3412495-drug-wholesalers-in-green-on-looming-close-of-cvs-aetna-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3412495-drug-wholesalers-in-green-on-looming-close-of-cvs-aetna-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412494\" data-ts=\"1543341931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLMT\" target=\"_blank\">BLMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412494-bsb-bancorp-leads-financial-gainers-marine-petroleum-and-community-west-bancshares-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BSB Bancorp leads financial gainers; Marine Petroleum and Community West Bancshares among losers</a></h4><ul> <li>\n<b>Gainers:</b> BSB Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/BLMT' title='BSB Bancorp, Inc.'>BLMT</a>) <font color=\"green\">+16%</font>. Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a>) <font color=\"green\">+11%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"green\">+7%</font>. CPI Card Group (NASDAQ:<a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a>) <font color=\"green\">+7%</font>. LGI Homes (NASDAQ:<a href='https://seekingalpha.com/symbol/LGIH' title='LGI Homes, Inc.'>LGIH</a>) <font color=\"green\">+7%</font>.</li> <li>\n<b>Losers:</b> EverQuote (NASDAQ:<a href='https://seekingalpha.com/symbol/EVER' title='EverQuote'>EVER</a>) <font color=\"red\">-9%</font>. Community West Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBC' title='Community West Bancshares'>CWBC</a>) <font color=\"red\">-8%</font>. Income Opportunity Realty Investors (NYSEMKT:<a href='https://seekingalpha.com/symbol/IOR' title='Income Opportunity Realty Investors, Inc'>IOR</a>) <font color=\"red\">-8%</font>. Marine Petroleum Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/MARPS' title='Marine Petroleum Trust'>MARPS</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412494\" data-linked=\"BSB Bancorp leads financial gainers; Marine Petroleum and Community West Bancshares among losers\" data-tweet=\"$BLMT $BLMT $IIPR - BSB Bancorp leads financial gainers; Marine Petroleum and Community West Bancshares among losers https://seekingalpha.com/news/3412494-bsb-bancorp-leads-financial-gainers-marine-petroleum-and-community-west-bancshares-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3412494-bsb-bancorp-leads-financial-gainers-marine-petroleum-and-community-west-bancshares-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412492\" data-ts=\"1543341683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLTZY\" target=\"_blank\">TLTZY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412492-ec-grants-unconditional-ok-to-dutch-combo-of-deutsche-telekom-tele2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EC grants unconditional OK to Dutch combo of Deutsche Telekom, Tele2</a></h4><ul>   <li>The European Commission has given an uncommon unconditional approval to Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"green\">+0.4%</font>) for its deal to buy the Dutch mobile business of Tele2 (<a href='https://seekingalpha.com/symbol/TLTZY' title='Tele2 AB ADR'>OTCPK:TLTZY</a>).</li>    <li>\"Our investigation found that the proposed acquisition would not significantly change the prices or quality of mobile services for Dutch consumers,\" the commission says.</li>    <li>That's due in large part to the fact that despite the move dropping the Netherlands' mobile market to three players from four, the combination of the No. 3 and No. 4 players will result in a market share of just under 30%, vs. No. 2 firm Vodafone Ziggo (<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a> <font color=\"green\">+1.8%</font>, <a href='https://seekingalpha.com/symbol/LBTYA' title='Liberty Global, Inc.'>LBTYA</a> <font color=\"red\">-2.1%</font>) with 30.5%, and leader Royal KPN (<a href=\"http://seekingalpha.com/symbol/KKPNY\" target=\"_blank\">KKPNY</a> <font color=\"red\">-1.8%</font>) with 43%.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412492\" data-linked=\"EC grants unconditional OK to Dutch combo of Deutsche Telekom, Tele2\" data-tweet=\"$TLTZY $TLTZY $VOD - EC grants unconditional OK to Dutch combo of Deutsche Telekom, Tele2 https://seekingalpha.com/news/3412492-ec-grants-unconditional-ok-to-dutch-combo-of-deutsche-telekom-tele2?source=tweet\" data-url=\"https://seekingalpha.com/news/3412492-ec-grants-unconditional-ok-to-dutch-combo-of-deutsche-telekom-tele2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412490\" data-ts=\"1543341635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WRE\" target=\"_blank\">WRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412490-washington-reit-slumps-jpmorgan-cuts-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Washington REIT slumps as JPMorgan cuts price target</a></h4><ul>\n<li>Washington Real Estate Investment Trust (NYSE:<a href='https://seekingalpha.com/symbol/WRE' title='Washington Real Estate Investment'>WRE</a>)<font color=\"red\"> falls 4.9%</font> in early afternoon trading after JPMorgan trims its price target to $28 from $32, noting WRE's leasing update reveals \"notable 2019 drags.\"</li>\n<li>Analyst Anthony Paolone estimates the REIT's office portfolio occupancy will lessen by about 300 basis points, on average, next year vs. 2018 levels.</li>\n<li>Source: Bloomberg First Word.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/WRE/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>: 2 buys; 4 holds; 0 underperform/sell.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3392534-washington-reit-said-shopping-retail-portfolio-bloomberg\" target=\"_blank\">Washington REIT is said to be shopping its retail portfolio: Bloomberg</a> (Sept. 24)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412490\" data-linked=\"Washington REIT slumps as JPMorgan cuts price target\" data-tweet=\"$WRE - Washington REIT slumps as JPMorgan cuts price target https://seekingalpha.com/news/3412490-washington-reit-slumps-jpmorgan-cuts-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3412490-washington-reit-slumps-jpmorgan-cuts-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412487\" data-ts=\"1543340899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDLP\" target=\"_blank\">SDLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412487-seadrill-partners-wins-11m-rig-deal-petronas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill Partners wins $11M rig deal with Petronas</a></h4><ul>\n<li>Seadrill Partners (<a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='red'>-3.9%</font>) says it has <a href=\"https://www.offshoreenergytoday.com/new-gig-to-keep-seadrill-rig-in-malaysia/\" target=\"_blank\">secured a contract</a> for its <em>West Capella</em> drillship for one well with two options with Petronas in Malaysia.</li>\n<li>SDLP expects backlog for the firm portion of the contract of ~$11M, and commencement is expected in Q3 2019.</li>\n<li>The rig currently is drilling for Shell in Malaysia under a five-well contract signed in July, with the backlog excluding options expected to total $32M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412487\" data-linked=\"Seadrill Partners wins $11M rig deal with Petronas\" data-tweet=\"$SDLP $SDLPF - Seadrill Partners wins $11M rig deal with Petronas https://seekingalpha.com/news/3412487-seadrill-partners-wins-11m-rig-deal-petronas?source=tweet\" data-url=\"https://seekingalpha.com/news/3412487-seadrill-partners-wins-11m-rig-deal-petronas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412486\" data-ts=\"1543340678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNS\" target=\"_blank\">ASNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412486-healthcare-tech-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare &amp; Tech dominate midday movers</a></h4><ul>\n<li>\n<strong>Gainers:</strong> Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) <font color=\"green\">+81%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"green\">+22%</font>. Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) <font color=\"green\">+19%</font>. Cocrystal Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/COCP' title='Cocrystal Pharma, Inc.'>COCP</a>) <font color=\"green\">+19%</font>. Bluegreen Vacations (NYSE:<a href='https://seekingalpha.com/symbol/BXG' title='Bluegreen Vacations Corp.'>BXG</a>) <font color=\"green\">+16%</font>. BSB Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/BLMT' title='BSB Bancorp, Inc.'>BLMT</a>) <font color=\"green\">+16%</font>. CohBar (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBR' title='CohBar Inc.'>CWBR</a>) <font color=\"green\">+15%</font>. Spirit Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a>) <font color=\"green\">+15%</font>. Aileron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a>) <font color=\"green\">+13%</font>. Daqo New Energy (NYSE:<a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a>) <font color=\"green\">+12%</font>.</li> <li>\n<strong>Losers: </strong>Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"red\">-60%</font>. Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) <font color=\"red\">-20%</font>. G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a>) <font color=\"red\">-20%</font>. Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a>) <font color=\"red\">-17%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"red\">-16%</font>. Francesca's Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a>) <font color=\"red\">-16%</font>. Income Opportunity Realty Investors (NYSEMKT:<a href='https://seekingalpha.com/symbol/IOR' title='Income Opportunity Realty Investors, Inc'>IOR</a>) <font color=\"red\">-14%</font>. ReShape Lifesciences (<a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a>) <font color=\"red\">-15%</font>. Alta Mesa Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/AMR' title='Alta Mesa Resources, Inc.'>AMR</a>) <font color=\"red\">-14%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412486\" data-linked=\"Healthcare &amp; Tech dominate midday movers\" data-tweet=\"$ASNS $XFOR $ANY - Healthcare &amp; Tech dominate midday movers https://seekingalpha.com/news/3412486-healthcare-tech-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3412486-healthcare-tech-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412479\" data-ts=\"1543339210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412479-calamp-telefonica-team-on-telematics-supply-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp, Telefonica team on telematics supply deal</a></h4><ul>   <li>CalAmp (<a href=\"http://seekingalpha.com/symbol/CAMP\" target=\"_blank\">CAMP</a> <font color=\"red\">-1.7%</font>) and Telefonica (<a href=\"http://seekingalpha.com/symbol/TEF\" target=\"_blank\">TEF</a> <font color=\"green\">+0.1%</font>) have set a major <a href=\"https://seekingalpha.com/pr/17342000-calamp-telefonica-global-agreement-eases-migration-3g-mexico-expansion-anticipated-across\" target=\"_blank\">global supply agreement</a> for intelligent telematics devices.</li>    <li>Telefonica will offer \"IoT in a Box\" bundles that will include CalAmp's fleet and asset tracking devices along with Telefonica connectivity/visibility tools. Targets of the bundled services include fleet operators, vehicle financiers, auto dealers, insurers and rental car companies.</li>    <li>The deal provides devices for fleet and asset management in Mexico at first, with expected expansion across other Latin American and European markets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412479\" data-linked=\"CalAmp, Telefonica team on telematics supply deal\" data-tweet=\"$CAMP $CAMP $TEF - CalAmp, Telefonica team on telematics supply deal https://seekingalpha.com/news/3412479-calamp-telefonica-team-on-telematics-supply-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3412479-calamp-telefonica-team-on-telematics-supply-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412478\" data-ts=\"1543338630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412478-aws-using-efficient-arm-server-chips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AWS using more efficient ARM server chips</a></h4><ul>\n<li>Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+0.4%</font>) Web Services <a href=\"https://aws.amazon.com/blogs/aws/new-ec2-instances-a1-powered-by-arm-based-aws-graviton-processors/\" target=\"_blank\">begins using</a> more efficient ARM-based server chips with the AWS Graviton Processors announced at the re:Invent conference.</li>\n<li>Amazon says the processors are optimized for scale-out workloads that can spread across multiple smaller instances.</li>\n<li>The first set of instances (A1) is now available in select regions in the U.S. and Europe.</li>\n<li>AWS is moving to its Nitro System, which provides a framework for building instance types faster.</li>\n<li>Earlier this month, AWS announced support for AMD's (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+6.2%</font>) EPYC processors.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405924-amd-plus-5_6-percent-next-horizon-event-aws-instances-announcement\" target=\"_blank\">AMD +5.6% on Next Horizon event, AWS instances announcement</a> (Nov. 6)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412478\" data-linked=\"AWS using more efficient ARM server chips\" data-tweet=\"$AMZN $AMZN $AMD - AWS using more efficient ARM server chips https://seekingalpha.com/news/3412478-aws-using-efficient-arm-server-chips?source=tweet\" data-url=\"https://seekingalpha.com/news/3412478-aws-using-efficient-arm-server-chips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412476\" data-ts=\"1543338197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COCP\" target=\"_blank\">COCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412476-cocrystal-pharma-up-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CoCrystal Pharma up 18%</a></h4><ul> <li>Thinly traded nano cap Cocrystal Pharma (<a href='https://seekingalpha.com/symbol/COCP' title='Cocrystal Pharma, Inc.'>COCP</a> <font color=\"green\">+17.6%</font>) is up on modestly higher volume. Shares have more than doubled since touching $1.51 on November 5.</li> <li>Two weeks ago, President Sam Lee, Ph.D., <a href=\"https://seekingalpha.com/pr/17332226-cocrystal-pharma-announces-presentation-preclinical-characterization-data-ccminus-42344-6th\" target=\"_blank\">presented</a> preclinical data on influenza A candidate CC-42344 at a respiratory virus conference in Washington, DC.</li> <li>On the working capital front, at the end of September, it had $4.7M in cash while operations consumed $6.3M ytd from January 1.</li> <li>In July, the company inked a $10M stock sales <a href=\"https://www.sec.gov/Archives/edgar/data/1412486/000149315218010283/form424b5.htm\" target=\"_blank\">agreement</a> with Ladenburg Thalmann whose chairman is Dr. Phillip Frost, currently one of the targets in a stock fraud investigation. He is also on the board of COCP.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412476\" data-linked=\"CoCrystal Pharma up 18%\" data-tweet=\"$COCP - CoCrystal Pharma up 18% https://seekingalpha.com/news/3412476-cocrystal-pharma-up-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3412476-cocrystal-pharma-up-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412470\" data-ts=\"1543337901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STKL\" target=\"_blank\">STKL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412470-sunopta-leads-consumer-gainers-fossil-group-and-orchids-paper-products-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunOpta leads consumer gainers; Fossil Group and Orchids Paper Products among losers</a></h4><ul> <li>\n<b>Gainers:</b> SunOpta (NASDAQ:<a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a>) <font color=\"green\">+12%</font>. China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> G-III Apparel Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a>) <font color=\"red\">-9%</font>. Fossil Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a>) <font color=\"red\">-7%</font>. Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412470\" data-linked=\"SunOpta leads consumer gainers; Fossil Group and Orchids Paper Products among losers\" data-tweet=\"$STKL $STKL $CAAS - SunOpta leads consumer gainers; Fossil Group and Orchids Paper Products among losers https://seekingalpha.com/news/3412470-sunopta-leads-consumer-gainers-fossil-group-and-orchids-paper-products-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3412470-sunopta-leads-consumer-gainers-fossil-group-and-orchids-paper-products-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412468\" data-ts=\"1543337812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WGO\" target=\"_blank\">WGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412468-rv-industry-expected-to-see-drop-in-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RV industry expected to see drop in 2019</a></h4><ul> <li>RV shipments will fall in 2019 to a range of 439.8K to 466K units from this year's estimated level of 479K and the 504.6K shipments recorded in 2017, according to a forecast from Richard Curtin of the University of Michigan Survey Research Center.</li> <li>\"Income, employment, and household wealth will continue to exert a positive force on RV sales, though these factors are expected to be slightly less favorable in the year ahead,\" updates Curtin.</li> <li>Last month, RV sales were down 11% Y/Y (per Bloomberg).</li> <li>Sector watch: Winnebago (<a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color=\"red\">-2.9%</font>), Thor Industries (<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color=\"red\">-2.1%</font>), LCI Industries (<a href='https://seekingalpha.com/symbol/LCII' title='LCI Industries'>LCII</a> <font color=\"green\">+0.4%</font>), Patrick Industries (<a href='https://seekingalpha.com/symbol/PATK' title='Patrick Industries, Inc.'>PATK</a> <font color=\"green\">+0.4%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412468\" data-linked=\"RV industry expected to see drop in 2019\" data-tweet=\"$WGO $WGO $THO - RV industry expected to see drop in 2019 https://seekingalpha.com/news/3412468-rv-industry-expected-to-see-drop-in-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3412468-rv-industry-expected-to-see-drop-in-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412464\" data-ts=\"1543337232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412464-egyptian-billionaire-eyes-barrick-s-african-gold-mines-after-randgold-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Egyptian billionaire eyes Barrick\u2019s African gold mines after Randgold merger</a></h4><ul>\n<li>Egyptian billionaire Naguib Sawiris outlines plans to build a new African-focused gold company and says he would be <a href=\"https://www.ft.com/content/af2c8ff8-f246-11e8-ae55-df4bf40f9d0d\" target=\"_blank\">interested in buying any gold mines</a> on the continent put up for sale by Barrick Gold (ABX <font color='red'>-2.8%</font>) following its merger with Randgold (<a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='red'>-2.7%</font>).</li>\n<li>Sawiris tells the Mines and Money conference in London that he wants to use Ghana-based gold miner Golden Star, in which he bought a 30% stake in August, as a vehicle to acquire underground gold mines, mainly in east Africa.</li>\n<li>He says he met ABX CEO John Thornton recently in New York and expressed his interest in buying some of the  company\u2019s African mines.</li>\n<li>Analysts have speculated that ABX could sell Randgold\u2019s Tongon,  Massawa and Morila mines in Africa after the deal closes at the end of  the year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412464\" data-linked=\"Egyptian billionaire eyes Barrick\u2019s African gold mines after Randgold merger\" data-tweet=\"$GOLD - Egyptian billionaire eyes Barrick\u2019s African gold mines after Randgold merger https://seekingalpha.com/news/3412464-egyptian-billionaire-eyes-barrick-s-african-gold-mines-after-randgold-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3412464-egyptian-billionaire-eyes-barrick-s-african-gold-mines-after-randgold-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412463\" data-ts=\"1543336947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALRN\" target=\"_blank\">ALRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412463-aileron-up-14-on-study-collaboration-pfizer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aileron up 14% on study collaboration with Pfizer</a></h4><ul> <li>Thinly traded nano cap Aileron Therapeutics (<a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a> <font color=\"green\">+14%</font>) is up on more than double normal volume, albeit on turnover of only 187K shares, on the heels of its announced <a href=\"https://seekingalpha.com/pr/17341995-aileron-enters-clinical-trial-collaboration-pfizer-evaluate-alrnminus-6924-combination\" target=\"_blank\">collaboration </a>with Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+0.4%</font>) on a clinical trial evaluating the combination of lead candidate ALRN-6924 and IBRANCE (palbociclib) in MDM2-amplified cancers.</li> <li>The Phase 1b study in patients with solid tumors will launch next quarter. Aileron will conduct the trial while Pfizer will supply product.</li> <li>ALRN-6924 is a cell-permeating peptide that mimics the p53 tumor suppressor protein to disrupt the interaction with proteins that interfere with its action called <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161369/\" target=\"_blank\">MDMX and MDM2</a>.</li> <li>Palbociclib inhibits two enzymes, CDK4 and CDK6, that play key roles in the cell cycle. Blocking their action interferes with cancer cell proliferation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412463\" data-linked=\"Aileron up 14% on study collaboration with Pfizer\" data-tweet=\"$ALRN $ALRN $PFE - Aileron up 14% on study collaboration with Pfizer https://seekingalpha.com/news/3412463-aileron-up-14-on-study-collaboration-pfizer?source=tweet\" data-url=\"https://seekingalpha.com/news/3412463-aileron-up-14-on-study-collaboration-pfizer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412458\" data-ts=\"1543335919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412458-gold-fields-says-south-deep-job-cuts-last-resort-minister-lashes-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields says South Deep job cuts a last resort as minister lashes out</a></h4><ul>\n<li>Gold Fields (<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='red'>-2.8%</font>) says it has acted in good faith and that the planned cuts of ~1,100 employees, 30% of its workforce, at its South Deep mine are a \"<a href=\"http://www.miningweekly.com/article/gold-fields-insists-south-deep-retrenchments-are-a-last-resort-2018-11-27\" target=\"_blank\">last resort</a>.\"</li>\n<li>The statement follows comments yesterday from Mineral Resources Minister Mantashe that GFI had <a href=\"http://www.miningweekly.com/article/mantashe-unhappy-with-gold-fields-after-job-talks-2018-11-27\" target=\"_blank\">not acted in good faith</a> in talks with the government about the job cuts, in a setback for negotiations aimed at ending a weeks-long strike.</li>\n<li>GFI has \"merely engaged in a tick-box exercise for compliance purposes,\" Mantashe said after a meeting with company execs including CEO Nick Holland and representatives of the NUM union.</li>\n<li>The miner says South Deep had been losing more than R100M per month prior to the restructuring, which resulted in fewer job cuts than would have been necessary otherwise.</li>\n<li>Meanwhile, GFI says it recently engaged with NUM on a proposed settlement agreement aimed at resolving the strike at South Deep; the union has until the end of this week to accept the proposed settlement.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412458\" data-linked=\"Gold Fields says South Deep job cuts a last resort as minister lashes out\" data-tweet=\"$GFI - Gold Fields says South Deep job cuts a last resort as minister lashes out https://seekingalpha.com/news/3412458-gold-fields-says-south-deep-job-cuts-last-resort-minister-lashes-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3412458-gold-fields-says-south-deep-job-cuts-last-resort-minister-lashes-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412445\" data-ts=\"1543334438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNS\" target=\"_blank\">ASNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412445-arsanis-and-cohbar-among-healthcare-gainers-g1-therapeutics-and-reshape-lifesciences-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arsanis and CohBar among Healthcare gainers; G1 Therapeutics and ReShape Lifesciences among the losers</a></h4><ul> <li>\n<b>Gainers: </b>Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) <font color=\"green\">+71%</font>. CohBar (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBR' title='CohBar Inc.'>CWBR</a>) <font color=\"green\">+16%</font>. Cocrystal Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/COCP' title='Cocrystal Pharma, Inc.'>COCP</a>) <font color=\"green\">+15%</font>. Zymeworks (NYSE:<a href='https://seekingalpha.com/symbol/ZYME' title='Zymeworks'>ZYME</a>) <font color=\"green\">+12%</font>. Aileron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a>) <font color=\"green\">+11%</font>.</li> <li>\n<b>Losers: </b>G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a>) <font color=\"red\">-20%</font>. ReShape Lifesciences (<a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a>) <font color=\"red\">-17%</font>. Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a>) <font color=\"red\">-12%</font>. Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) <font color=\"red\">-12%</font>. Sunesis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412445\" data-linked=\"Arsanis and CohBar among Healthcare gainers; G1 Therapeutics and ReShape Lifesciences among the losers\" data-tweet=\"$ASNS $XFOR $CWBR - Arsanis and CohBar among Healthcare gainers; G1 Therapeutics and ReShape Lifesciences among the losers https://seekingalpha.com/news/3412445-arsanis-and-cohbar-among-healthcare-gainers-g1-therapeutics-and-reshape-lifesciences-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3412445-arsanis-and-cohbar-among-healthcare-gainers-g1-therapeutics-and-reshape-lifesciences-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412443\" data-ts=\"1543334396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412443-health-insurance-innovations-down-6-on-bearish-blog-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations down 6% on bearish blog post</a></h4><ul> <li>Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color=\"red\">-5.6%</font>) is down on almost double normal volume in apparent reaction to a <a href=\"https://aureliusvalue.com/research/hiiq-boiler-rooms-worthless-policies-and-defrauded-families/\" target=\"_blank\">bearish post</a> from Aurelius Value citing its relationship with fraudster Steve Dorfman who, it says, has been responsible for half of the company's revenues.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3298239-health-insurance-innovations-pressure-alleged-ties-dubious-brokers-shares-29-percent\" target=\"_blank\">Health Insurance Innovations under pressure again on alleged ties to dubious brokers; shares down 29%</a> (Sept. 28, 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412443\" data-linked=\"Health Insurance Innovations down 6% on bearish blog post\" data-tweet=\"$HIIQ - Health Insurance Innovations down 6% on bearish blog post https://seekingalpha.com/news/3412443-health-insurance-innovations-down-6-on-bearish-blog-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3412443-health-insurance-innovations-down-6-on-bearish-blog-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412441\" data-ts=\"1543334153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMYT\" target=\"_blank\">MMYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412441-makemytripplus-4_4-nomura-goes-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MakeMyTrip +4.4% as Nomura goes Buy</a></h4><ul>\n<li>Nomura Instinet <a href=\"https://www.streetinsider.com/Upgrades/NomuraInstinet+Upgrades+MakeMyTrip+%28MMYT%29+to+Buy/14864965.html\" target=\"_blank\">upgrades</a> MakeMyTrip (NASDAQ:<a href='https://seekingalpha.com/symbol/MMYT' title='MakeMyTrip Limited'>MMYT</a>) from Neutral to Buy and raises the price target from $31 to $35.</li>\n<li>Firm cites the recent pullback in shares. Nomura looks for revenue CAGR of 17% over FY18 to FY21 and continues to believe break-even is possible at the end of that period, a year later than management's guidance.</li>\n<li>MakeMyTrip shares are <font color=\"green\">up 4.4%</font> to $24.00.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412441\" data-linked=\"MakeMyTrip +4.4% as Nomura goes Buy\" data-tweet=\"$MMYT - MakeMyTrip +4.4% as Nomura goes Buy https://seekingalpha.com/news/3412441-makemytripplus-4_4-nomura-goes-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3412441-makemytripplus-4_4-nomura-goes-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412439\" data-ts=\"1543333974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVE\" target=\"_blank\">SAVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412439-airline-stocks-up-after-strong-pricing-read-from-spirit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks up after strong pricing read from Spirit</a></h4><ul>\n<li>Spirit Airline (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a>) <font color=\"green\">rallies 18%</font> after the company issued a positive tone on industry-wide pricing, which could add to some of the benefits the company is seeing from nonticket pricing initiatives. Shares of Spirit reached a multi-year high of $61.98 earlier in the day.</li>\n<li>Spirit's pricing reads tend to be noticed across the sector. Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='green'>+2.8%</font>), JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='green'>+1.8%</font>), Alaska Air (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='green'>+1.2%</font>) and Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='green'>+1.1%</font>) are all gainers today.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412439\" data-linked=\"Airline stocks up after strong pricing read from Spirit\" data-tweet=\"$SAVE $SAVE $DAL - Airline stocks up after strong pricing read from Spirit https://seekingalpha.com/news/3412439-airline-stocks-up-after-strong-pricing-read-from-spirit?source=tweet\" data-url=\"https://seekingalpha.com/news/3412439-airline-stocks-up-after-strong-pricing-read-from-spirit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412435\" data-ts=\"1543333867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHAS\" target=\"_blank\">PHAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412435-dosing-underway-in-phasebios-mid-stage-study-of-pb1046-in-pah-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dosing underway in Phasebio&#39;s mid-stage study of PB1046 in PAH; shares up 3%</a></h4><ul> <li>Relatively recent IPO PhaseBio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals'>PHAS</a> <font color=\"green\">+2.7%</font>) is up on below-average volume following its <a href=\"https://seekingalpha.com/pr/17341929-phasebio-announces-dosing-first-patient-phase-2b-clinical-trial-pb1046-pulmonary-arterial\" target=\"_blank\">announcement</a> that the first patient has been dosed in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03556020?term=NCT03556020&amp;rank=1\" target=\"_blank\">Phase 2b clinical trial</a> evaluating PB1046 in patients with pulmonary arterial hypertension &#40;PAH&#41;.</li> <li>The 60-subject study will assess the effects of weekly injections of PB1046, a fusion protein, on pulmonary hemodynamics and exercise tolerance. The estimated completion date is January 2020.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412435\" data-linked=\"Dosing underway in Phasebio&#39;s mid-stage study of PB1046 in PAH; shares up 3%\" data-tweet=\"$PHAS - Dosing underway in Phasebio&#39;s mid-stage study of PB1046 in PAH; shares up 3% https://seekingalpha.com/news/3412435-dosing-underway-in-phasebios-mid-stage-study-of-pb1046-in-pah-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3412435-dosing-underway-in-phasebios-mid-stage-study-of-pb1046-in-pah-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412431\" data-ts=\"1543332867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNOP\" target=\"_blank\">KNOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412431-on-knot-offshore-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on KNOT Offshore Q3 results</a></h4><ul> <li>KNOT Offshore (<a href='https://seekingalpha.com/symbol/KNOP' title='KNOT Offshore Partners LP'>KNOP</a> <font color=\"green\">+0.6%</font>) reports <a href=\"https://seekingalpha.com/pr/17341348-knot-offshore-partners-lp-earnings-release-interim-results-period-ended-september-30-2018\" target=\"_blank\">Q</a><a href=\"https://seekingalpha.com/pr/17341348-knot-offshore-partners-lp-earnings-release-interim-results-period-ended-september-30-2018\" target=\"_blank\">3</a> revenue growth of 21.5% Y/Y to $70.7M.</li> <li>Fleet operated with 99.9% utilization for scheduled operations and 97.4% utilization taking into account the scheduled drydocking of the Hilda Knutsen and Torill Knutsen, which were offhire for 24 and 14 days, respectively, in Q3.</li> <li>Q3 overall margins: Operating <font color=\"red\">declined 104 bps</font> to 44.8% &amp; Adj. EBITDA <font color=\"red\">declined 1,695 bps</font> to 76.5% compared Q/Q.</li> <li>Generated distributable cash flow of $26.3M (+29.8% Q/Q); declared quarterly cash distribution of $0.52 per share &amp; distribution coverage ratio of 1.46.</li> <li>Also, had $78.7M in available liquidity; cash &amp; equivalents of $56M and $22.7M of capacity under its revolving credit facilities.</li> <li>The average margin paid on the Partnership\u2019s outstanding debt was ~2.1% over LIBOR.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3412171-knot-offshore-partners-beats-revenue\" target=\"_blank\">KNOT Offshore Partners beats on revenue</a> (Nov. 26 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412431\" data-linked=\"More on KNOT Offshore Q3 results\" data-tweet=\"$KNOP - More on KNOT Offshore Q3 results https://seekingalpha.com/news/3412431-on-knot-offshore-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3412431-on-knot-offshore-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412428\" data-ts=\"1543332433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412428-auto-sector-jittery-on-new-tariff-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto sector jittery on new tariff talk</a></h4><ul> <li>General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='red'>-1.1%</font>), Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color='red'>-0.9%</font>) and Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-1.9%</font>) all trade a bit lower as global growth uncertainty and tariff headaches continue to dominate the discussion. Ahead of the G-20 meeting, there are reports out indicating that President Trump is considering automobile tariffs as early as next week. Whether or not the tariff threat ends up being a negotiating tactic, automobile companies are already suffering on their bottom lines from the higher costs of steel and aluminum that can't be passed on in full to consumers.</li> <li>Across the pond the declines are worse, Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>) is <font color=\"red\">down 2.2%</font> in Frankfurt and Volkswagen (<a href='https://seekingalpha.com/symbol/VWAGY' title='Volkswagen AG ADR'>OTCPK:VWAGY</a>) is <font color=\"red\">2.5% lower</font>. BMW (<a href='https://seekingalpha.com/symbol/BMWYY' title='Bayerische Motoren Werke AG ADR'>OTCPK:BMWYY</a>) is also in harm's way, but only trades <font color=\"red\">1.3% lower</font> in overseas afternoon action.</li> <li>Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-2%</font>) and Tata Motors (<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='red'>-1.7%</font>) are also notably lower on the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412428\" data-linked=\"Auto sector jittery on new tariff talk\" data-tweet=\"$GM $GM $F - Auto sector jittery on new tariff talk https://seekingalpha.com/news/3412428-auto-sector-jittery-on-new-tariff-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3412428-auto-sector-jittery-on-new-tariff-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412419\" data-ts=\"1543332374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTHX\" target=\"_blank\">GTHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412419-g1-therapeutics-down-18-on-mixed-results-from-mid-stage-study-of-trilaciclib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">G1 Therapeutics down 18% on mixed results from mid-stage study of trilaciclib</a></h4><ul> <li>Thinly traded G1 Therapeutics (<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a> <font color=\"red\">-17.6%</font>) slumps on average volume on the heels the results from a Phase 2 clinical evaluating trilaciclib in first-line small cell lung cancer.</li> <li>The drug demonstrated an effect in preserving immune system function but failed to sufficiently separate from placebo in terms of overall survival, progression-free survival and duration of response.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412212-g1-therapeutics-trilaciclib-preserves-immune-system-function-mid-stage-lung-cancer-study\" target=\"_blank\">G1 Therapeutics' trilaciclib preserves immune system function in mid-stage lung cancer study</a> (Nov. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412419\" data-linked=\"G1 Therapeutics down 18% on mixed results from mid-stage study of trilaciclib\" data-tweet=\"$GTHX - G1 Therapeutics down 18% on mixed results from mid-stage study of trilaciclib https://seekingalpha.com/news/3412419-g1-therapeutics-down-18-on-mixed-results-from-mid-stage-study-of-trilaciclib?source=tweet\" data-url=\"https://seekingalpha.com/news/3412419-g1-therapeutics-down-18-on-mixed-results-from-mid-stage-study-of-trilaciclib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412421\" data-ts=\"1543331486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YIN\" target=\"_blank\">YIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412421-yintechplus-2_2-after-sequential-improvement-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yintech +2.2% after sequential improvement in Q3</a></h4><ul>\n<li>Yintech (NASDAQ:<a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a>) <font color=\"green\">gains 2.2% </font>after <a href=\"https://seekingalpha.com/pr/17341743-yintech-reports-third-quarter-2018-unaudited-financial-results\" target=\"_blank\">Q3 adjusted loss per ADS</a> narrowed to RMB 0.31 from a loss of RMB 0.41 per ADS in Q2.</li>\n<li>Q3 revenue of RMB 267.8M ($39.0M) rose 1.7% Q/Q and fell 31% Y/Y.</li>\n<li>Sees Q4 revenue of RMB 280.0M-RMB 300.0M.</li>\n<li>Chairman and CEO Wenbin Chin says the company is realigning its focus on client education and introducing new products and value-added services, \"as well as investing in new business initiatives to better serve our premium customers.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412294-yintech-investment-reports-q3-results\" target=\"_blank\">Yintech Investment reports Q3 results</a> (Nov. 27)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412421\" data-linked=\"Yintech +2.2% after sequential improvement in Q3\" data-tweet=\"$YIN - Yintech +2.2% after sequential improvement in Q3 https://seekingalpha.com/news/3412421-yintechplus-2_2-after-sequential-improvement-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3412421-yintechplus-2_2-after-sequential-improvement-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412414\" data-ts=\"1543330876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DARE\" target=\"_blank\">DARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412414-dar-bioscience-launches-thermography-study-of-sildenafil-cream-in-women-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daré Bioscience launches thermography study of Sildenafil Cream in women; shares ahead 2%</a></h4><ul> <li>Thinly traded nano cap Daré Bioscience (<a href='https://seekingalpha.com/symbol/DARE' title='Dare Bioscience, Inc.'>DARE</a>) is up <font color=\"green\">2%</font> in early trade, albeit on only 110 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17341990-dare-bioscience-inc-announces-enrollment-thermography-feasibility-study-sildenafil-cream-3_6\" target=\"_blank\">announcement </a>that enrollment is underway in an investigational study assessing the pharmacodynamics of Sildenafil Cream, 3.6% in healthy women. The company is developing the topical product for the potential treatment of female sexual arousal disorder.</li> <li>The study will use thermography technology, specifically a infrared camera, to measure genital temperature, a surrogate for genital blood flow.</li> <li>The results will inform on the design of a Phase 2b study expected to launch in 2019.</li> <li>Sildenafil is the active ingredient in Pfizer's Viagra.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412414\" data-linked=\"Daré Bioscience launches thermography study of Sildenafil Cream in women; shares ahead 2%\" data-tweet=\"$DARE - Daré Bioscience launches thermography study of Sildenafil Cream in women; shares ahead 2% https://seekingalpha.com/news/3412414-dar-bioscience-launches-thermography-study-of-sildenafil-cream-in-women-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3412414-dar-bioscience-launches-thermography-study-of-sildenafil-cream-in-women-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412413\" data-ts=\"1543330801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOUR\" target=\"_blank\">TOUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412413-tuniuminus-4_7-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tuniu -4.7% post Q3 results</a></h4><ul> <li>Tuniu (<a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a> <font color=\"red\">-4.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17341690-tuniu-announces-unaudited-third-quarter-2018-financial-results\" target=\"_blank\">Q3</a> revenue decrease of 5.3% Y/Y to RMB763.1M.</li> <li>Packaged tours revenues were RMB632.7M (+4.7% Y/Y), the increase was primarily due to the growth of organized tours.</li> <li>Other revenues were RMB130.4M (-35.5% Y/Y).</li> <li>Gross profit was RMB391.5M (-11.2% Y/Y), the decrease was primarily due to the decrease in other revenues.</li> <li>Adj. operating expenses were RMB340.7M (-22.7% Y/Y).</li> <li>The Company had cash, equivalents, restricted cash and short-term investments of RMB1.9B.</li> <li>As of October 31, 2018, Tuniu had 415 offline retail stores in total, of which 251 were newly added since January 1, 2018.</li> <li>As of November 27, 2018, Tuniu had 26 local tour operators in total, including 1 newly launched local tour operator overseas<sup> </sup>since July 31, 2018.</li> <li>\n<b>Q4 Outlook:</b> Net revenues of RMB422.9-446.4M, which represents 5-10% decrease Y/Y.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3412279-tuniu-reports-q3-results\" target=\"_blank\">Tuniu reports Q3 results</a> (Nov. 27 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412413\" data-linked=\"Tuniu -4.7% post Q3 results\" data-tweet=\"$TOUR - Tuniu -4.7% post Q3 results https://seekingalpha.com/news/3412413-tuniuminus-4_7-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3412413-tuniuminus-4_7-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412391\" data-ts=\"1543328490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRCM\" target=\"_blank\">CRCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412391-care-comminus-5_9-prices-475k-share-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Care.com -5.9% as it prices 475K-share secondary</a></h4><ul>   <li>Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) is <font color=\"red\">5.9% lower</font> premarket on reports that it's pricing a 475K-share offering for a selling shareholder.</li>    <li>The shares are being offered at $17.85/share, Bloomberg reports; that's a 1.8% discount from yesterday's closing price.</li>    <li>Sellers are unknown but more than 10 holders own at least 475,000 shares, Bloomberg says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412391\" data-linked=\"Care.com -5.9% as it prices 475K-share secondary\" data-tweet=\"$CRCM - Care.com -5.9% as it prices 475K-share secondary https://seekingalpha.com/news/3412391-care-comminus-5_9-prices-475k-share-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3412391-care-comminus-5_9-prices-475k-share-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412384\" data-ts=\"1543327858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEMD\" target=\"_blank\">AEMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412384-fro-save-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FRO, SAVE among premarket gainers</a></h4><ul> <li>Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) <font color=\"green\">+37%</font> on accelerated review <a href=\"https://seekingalpha.com/news/3412345-aethlon-medical-75-percent-premarket-accelerated-review-status-hemopurifier-cancer\" target=\"_blank\">status</a> for Hemopurifier in cancer.</li> <li>Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) <font color=\"green\">+20%</font> on <a href=\"https://seekingalpha.com/pr/17341821-arsanis-x4-pharmaceuticals-agree-merger\" target=\"_blank\">merger</a> with X4 Pharmaceuticals.</li> <li>Spirit Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a>) <font color=\"green\">+12%</font> on Q4 <a href=\"https://seekingalpha.com/news/3412257-spirit-airlines-soars-10-percent-q4-guidance\" target=\"_blank\">guidance</a>.</li> <li>Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"green\">+11%</font>.</li> <li>Frontline (NYSE:<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a>) <font color=\"green\">+9%</font> after <a href=\"https://seekingalpha.com/news/3412343-frontline-plus-12-percent-upgrade\" target=\"_blank\">upgrade</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412384\" data-linked=\"FRO, SAVE among premarket gainers\" data-tweet=\"$AEMD $AEMD $XFOR - FRO, SAVE among premarket gainers https://seekingalpha.com/news/3412384-fro-save-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3412384-fro-save-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412380\" data-ts=\"1543327672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSM\" target=\"_blank\">GSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412380-gsm-and-amrn-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSM and AMRN among premarket losers</a></h4><ul> <li>Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"red\">-40%</font> on <a href=\"https://seekingalpha.com/news/3412347-ferroglobe-minus-32-percent-q3-miss-curtail-production-silicon-metal-manganese-based-alloys\" target=\"_blank\">Q3 earnings</a>.</li> <li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3412266-amarin-prices-public-offering-ads\" target=\"_blank\">pricing</a> public offering of ADS.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412380\" data-linked=\"GSM and AMRN among premarket losers\" data-tweet=\"$GSM $GSM $AMRN - GSM and AMRN among premarket losers https://seekingalpha.com/news/3412380-gsm-and-amrn-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3412380-gsm-and-amrn-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412373\" data-ts=\"1543327144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412373-jefferies-turns-cautious-on-hormel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies turns cautious on Hormel</a></h4><ul> <li>Shares of Hormel are on watch after Jefferies drops its rating on the food products company to Hold from Buy.</li> <li>The firm assigns a price target of $44 to Hormel.</li> <li>HRL <font color=\"red\">-1.33%</font> premarket to $45.10 vs. a 52-week trading range of $31.71 to $46.26.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412373\" data-linked=\"Jefferies turns cautious on Hormel\" data-tweet=\"Jefferies turns cautious on Hormel https://seekingalpha.com/news/3412373-jefferies-turns-cautious-on-hormel?source=tweet\" data-url=\"https://seekingalpha.com/news/3412373-jefferies-turns-cautious-on-hormel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412372\" data-ts=\"1543327110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412372-mallinckrodt-defends-acthar-gel-shares-up-fraction-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mallinckrodt defends Acthar Gel; shares up a fraction premarket</a></h4><ul> <li>Reacting to yesterday's Citron Research-stoked <font color=\"red\">8%</font> selloff, Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a>) issues a <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=251847&amp;p=irol-newsArticle_print&amp;ID=2378298\" target=\"_blank\">statement </a>detailing its commitment to Acthar Gel and the extensive number of clinical trials supporting its efficacy.</li> <li>It also announces its Acthar Starter Program for Infantile Spasms under which healthcare providers will have access to the product in the hospital setting at no cost in order to avoid delays in treatment while reimbursement is pending.</li>\n<li>Shares are up a fraction premarket.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3412167-bearish-citron-tweets-pressure-mallinckrodt-11-percent\" target=\"_blank\">Bearish Citron tweets pressure Mallinckrodt, down 11%</a> (Nov. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412372\" data-linked=\"Mallinckrodt defends Acthar Gel; shares up a fraction premarket\" data-tweet=\"$MNK - Mallinckrodt defends Acthar Gel; shares up a fraction premarket https://seekingalpha.com/news/3412372-mallinckrodt-defends-acthar-gel-shares-up-fraction-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3412372-mallinckrodt-defends-acthar-gel-shares-up-fraction-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412362\" data-ts=\"1543326086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQUA\" target=\"_blank\">AQUA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412362-evoqua-waterplus-6-surprise-loss-attributed-to-one-off-items\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evoqua Water +6% as surprise loss attributed to one-off items</a></h4><ul> <li>Evoqua Water Technologies (NYSE:<a href='https://seekingalpha.com/symbol/AQUA' title='Evoqua Water Technologies Corp.'>AQUA</a>) <font color=\"green\">+5.9%</font> pre-market despite posting a surprise <a href=\"https://seekingalpha.com/news/3412307-evoqua-water-misses-0_08-beats-revenue\" target=\"_blank\">FQ4 loss</a>, which the company said was due mostly to one-off items.</li> <li>AQUA says Q4 earnings were hurt by \"isolated items,\" related to the integration of an acquisition, supply chain disruptions influenced by tariffs and an extended delay on a large aquatics project.</li> <li>\"We are taking the appropriate actions to improve our performance and we are pleased that Neptune Benson was migrated onto our ERP system in November,\" the company says.</li> <li>AQUA says its planned two-segment restructuring is progressing, and is expected to generate costs of $17M-$22M over the next two fiscal years with cost savings of $15M-$20M on an annualized basis.</li>\n<li>For Q1, AQUA forecasts revenues of $305M-$320M vs. $321M analyst consensus estimate; for FY 2019, the company sees revenues of $1.38B-$1.44B vs. $1.42B consensus.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412362\" data-linked=\"Evoqua Water +6% as surprise loss attributed to one-off items\" data-tweet=\"$AQUA - Evoqua Water +6% as surprise loss attributed to one-off items https://seekingalpha.com/news/3412362-evoqua-waterplus-6-surprise-loss-attributed-to-one-off-items?source=tweet\" data-url=\"https://seekingalpha.com/news/3412362-evoqua-waterplus-6-surprise-loss-attributed-to-one-off-items\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412347\" data-ts=\"1543324674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSM\" target=\"_blank\">GSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412347-ferroglobeminus-32-after-q3-miss-to-curtail-production-in-silicon-metal-manganese-based\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferroglobe -32% after Q3 miss; to curtail production in silicon metal, manganese-based alloys</a></h4><ul>\n<li>Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"red\">-32.1%</font> pre-market after posting wide misses on <a href=\"https://seekingalpha.com/news/3412220-ferroglobe-misses-0_15-misses-revenue\" target=\"_blank\">Q3 earnings</a> and revenues; Q3 adjusted EBITDA of $45M was 48% lower than Q2's $86.3M and 20% below $56.1M in the year-ago quarter.</li>\n<li>GSM says Q3 adjusted EBITDA margin was 8.5%, compared to 14.8% for Q2 and 12.4% for the year-earlier quarter.</li>\n<li>GSM says the average selling prices fell 5%-7% in Q3 for all of its products Q/Q, reflecting overall  market conditions; sales volumes also fell Q/Q, primarily due to seasonal slowdown in Europe and the impact of changing trade flows.</li>\n<li>Q3 cost of sales was $334.5M, an increase from $267.4M for the year-ago quarter, primarily driven by higher input costs for raw  materials and energy and higher volumes.</li>\n<li>GSM says it is curtailing production in its silicon metal and manganese-based alloys  businesses to focus on its most cost effective plants and  geographies.</li>\n<li>\"The deterioration in market conditions during the quarter left us with elevated inventories, a key factor in our decision to curtail our production,\" GSM says. \"Given our Q3 results, our free cash flow targets for the second half of 2018 have become a 'stretch' goal.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412347\" data-linked=\"Ferroglobe -32% after Q3 miss; to curtail production in silicon metal, manganese-based alloys\" data-tweet=\"$GSM - Ferroglobe -32% after Q3 miss; to curtail production in silicon metal, manganese-based alloys https://seekingalpha.com/news/3412347-ferroglobeminus-32-after-q3-miss-to-curtail-production-in-silicon-metal-manganese-based?source=tweet\" data-url=\"https://seekingalpha.com/news/3412347-ferroglobeminus-32-after-q3-miss-to-curtail-production-in-silicon-metal-manganese-based\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412345\" data-ts=\"1543324413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEMD\" target=\"_blank\">AEMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412345-aethlon-medical-up-75-premarket-on-accelerated-review-status-for-hemopurifier-in-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aethlon Medical up 75% premarket on accelerated review status for Hemopurifier in cancer</a></h4><ul>\n<li>Thinly traded nano cap Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) is up <font color=\"green\">75% </font>premarket on increased volume in apparent response to the FDA <a href=\"https://seekingalpha.com/pr/17341856-aethlon-medicals-cancer-therapy-receives-breakthrough-device-designation-u-s-food-drug\" target=\"_blank\">designating </a>the Hemopurifier a Breakthrough Device for the treatment of cancer, the second such designation for the product.</li>\n<li>The biofiltration device is designed to rapidly deplete cancer-promoting exosomes and life-threatening viruses from the blood.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3294819-fda-designates-aethlon-hemopurifier-accelerated-review-shares-ahead-35-percent-premarket\" target=\"_blank\">FDA designates Aethlon' Hemopurifier for accelerated review; shares ahead 35% premarket</a> (Sept. 12, 2017)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412345\" data-linked=\"Aethlon Medical up 75% premarket on accelerated review status for Hemopurifier in cancer\" data-tweet=\"$AEMD - Aethlon Medical up 75% premarket on accelerated review status for Hemopurifier in cancer https://seekingalpha.com/news/3412345-aethlon-medical-up-75-premarket-on-accelerated-review-status-for-hemopurifier-in-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3412345-aethlon-medical-up-75-premarket-on-accelerated-review-status-for-hemopurifier-in-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412344\" data-ts=\"1543324406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBRL\" target=\"_blank\">CBRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412344-cracker-barrel-beats-estimates-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cracker Barrel beats estimates in Q1</a></h4><ul>\n<li>Cracker Barrel (NASDAQ:<a href='https://seekingalpha.com/symbol/CBRL' title='Cracker Barrel Old Country Store, Inc.'>CBRL</a>) reports comparable restaurant sales rose 1.4% in <a href=\"https://seekingalpha.com/pr/17341980-cracker-barrel-reports-first-quarter-fiscal-2019-results-declares-quarterly-dividend\" target=\"_blank\">Q1</a>, including a 3% increase in average check offset by a 1.6% decrease in store traffic.</li>\n<li>Comparable retail sales grew 4.3%.</li>\n<li>The average menu price up ~2% for the quarter.</li>\n<li>Restaurant revenue advanced 2.2% to $590.98M.</li>\n<li>Retail revenue expanded 7.9% to $142.57M.</li>\n<li>Operating margin rate squeezed 160 bps to 8.4%.</li>\n<li>Store count +12 Y/Y to 663.</li>\n<li>\n<b>FY2019 Guidance</b>: Total revenue: ~$3.04B; Comparable store restaurant sales: flat to +1%; Comparable store retail sales: +1% to +2%; Depreciation expense: $110M to $115M; Net interest expense: ~$17M; Operating margin rate: 9% to 9.3%; Adjusted EPS: $8.95 to $9.10; Capex: ~$160M to $170M; Tax rate: ~17%.</li>\n<li>CBRL <font color=\"green\">+0.85%</font> premarket.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412341-cracker-barrel-beats-0_06-beats-revenue\" target=\"_blank\">Cracker Barrel beats by $0.06, beats on revenue</a> (Nov. 27)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412344\" data-linked=\"Cracker Barrel beats estimates in Q1\" data-tweet=\"$CBRL - Cracker Barrel beats estimates in Q1 https://seekingalpha.com/news/3412344-cracker-barrel-beats-estimates-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3412344-cracker-barrel-beats-estimates-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412342\" data-ts=\"1543324286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITK\" target=\"_blank\">MITK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412342-mitek-systemsplus-2_4-on-benchmark-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitek Systems +2.4% on Benchmark upgrade</a></h4><ul>\n<li>Mitek Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems Inc.'>MITK</a>)<font color=\"green\"> advances 2.4%</font> in premarket trading after Benchmark upgrades the stock to buy from hold, citing increased confidence after reports that Jeffrey Davison rescinded his resignation as CFO.</li>\n<li>\"We view Mr. Davison's return a vote of confidence in new CEO Max Carnecchia,\" analyst Mark Schappel wrote in a note.</li>\n<li>The news removes one of the last obstacles remaining in Miktek's efforts to fight the pending takeover proposal from Elliott-backed ASG Technologies, \"though any temporary upside may be short-lived as investors ponder the hedge fund's next moves.\"</li>\n<li>Source: Bloomberg First Word.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/MITK/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>: 5 buys; 1 hold; 0 underperform/sell.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3412087-mitek-systems-cfo-rescinds-resignation\" target=\"_blank\">Mitek Systems CFO rescinds resignation</a> (Nov. 26)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3411535-mitek-responds-elliotts-stake\" target=\"_blank\">Mitek responds to Elliott's stake</a> (Nov. 21)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412342\" data-linked=\"Mitek Systems +2.4% on Benchmark upgrade\" data-tweet=\"$MITK - Mitek Systems +2.4% on Benchmark upgrade https://seekingalpha.com/news/3412342-mitek-systemsplus-2_4-on-benchmark-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3412342-mitek-systemsplus-2_4-on-benchmark-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412332\" data-ts=\"1543322923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412332-seadrillplus-6-sees-improvement-in-contracting-rigs-market-for-2019minus-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill +6%; sees improvement in contracting rigs market for 2019-20</a></h4><ul>\n<li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>) <font color=\"green\">+6.6%</font> pre-market after reporting a bigger than expected $240M <a href=\"https://seekingalpha.com/news/3412280-seadrill-reports-9m-results\" target=\"_blank\">Q3 net loss</a> but saying it <a href=\"https://www.marketwatch.com/story/seadrill-posts-bigger-than-expected-loss-2018-11-27\" target=\"_blank\">sees signs of improvement</a> in the offshore drilling industry.</li>\n<li>Q3 revenue totaled $249M compared with a forecast of $284M and adjusted EBITDA came in at $46M; the company forecasts Q4 EBITDA of ~$35M.</li>\n<li>\"The fundamentals for our industry remain strong and there are improving signs through increased contracting activity, additional supply leaving the market and industry consolidation which should lead to better pricing in the future,\" SDRL says. \"We are already starting to see rate improvements for contracts starting in 2019-20.\"</li>\n<li>SDRL says it had seven floaters working for the full quarter at an average dayrate of $241K with two floaters completing contracts during the quarter, and seven jackups were working for the full quarter at a $99K average dayrate with two jackups starting during the quarter; economic utilization for floaters was 98% and 97% for jackups.</li>\n<li>The company's backlog as of Nov. 27 totaled $2.1B, with $296M added in backlog since the end of Q2.</li>\n<li>SDRL emerged from Chapter 11 bankruptcy in July after completing a restructuring.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412332\" data-linked=\"Seadrill +6%; sees improvement in contracting rigs market for 2019-20\" data-tweet=\"$SDRL - Seadrill +6%; sees improvement in contracting rigs market for 2019-20 https://seekingalpha.com/news/3412332-seadrillplus-6-sees-improvement-in-contracting-rigs-market-for-2019minus-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3412332-seadrillplus-6-sees-improvement-in-contracting-rigs-market-for-2019minus-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412329\" data-ts=\"1543322714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPW\" target=\"_blank\">DPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412329-dpw-leaps-10-after-announcing-crypto-mining-spinoff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DPW leaps 10% after announcing crypto mining spinoff</a></h4><ul> <li>Microcap DPW Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) <font color=\"green\">advances 10% </font>in premarket trading of 25,840 shares after announcing its board authorized <a href=\"https://seekingalpha.com/pr/17341753-dpw-holdings-authorizes-pursuit-spinoff-super-crypto-mining-inc-special-dividend-stockholders\" target=\"_blank\">pursuing a spinoff</a> of its Super Crypto Mining unit.</li> <li>Intends to declare a distribution of shares of Super Crypto common stock to stockholders of DPW.</li> <li>\"It is our intent to declare a special dividend of no less than 80% of the common stock of Super Crypto to DPW stockholders,\u201d says CEO and Chairman Milton \"Todd\" Ault, III.</li> <li>The spinoff will allow each company's management teams to focus on its operations and also should help analysts, market makers and others better ascertain the value of each entity.</li> <li>Any plan the company devises will be subject to approval by DPW's senior secured creditor and certain regulatory bodies.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3410805-dpw-holdings-announces-expansion-plan-iam-inc\" target=\"_blank\">DPW Holdings announces expansion plan with IAM, Inc.</a> (Nov. 19)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412329\" data-linked=\"DPW leaps 10% after announcing crypto mining spinoff\" data-tweet=\"$DPW - DPW leaps 10% after announcing crypto mining spinoff https://seekingalpha.com/news/3412329-dpw-leaps-10-after-announcing-crypto-mining-spinoff?source=tweet\" data-url=\"https://seekingalpha.com/news/3412329-dpw-leaps-10-after-announcing-crypto-mining-spinoff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412324\" data-ts=\"1543322330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHN\" target=\"_blank\">ATHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412324-cantor-sees-23-upside-in-cvs-health-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cantor sees 23% upside in CVS Health in premarket analyst action</a></h4><ul>\n<li>Athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) resumed with Market Perform rating and $135 (2% upside) price target at Wells Fargo.</li>\n<li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) initiated with Overweight rating and $96 (23% upside) price target at Cantor Fitzgerald.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412324\" data-linked=\"Cantor sees 23% upside in CVS Health in premarket analyst action\" data-tweet=\"$ATHN $ATHN $CVS - Cantor sees 23% upside in CVS Health in premarket analyst action https://seekingalpha.com/news/3412324-cantor-sees-23-upside-in-cvs-health-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3412324-cantor-sees-23-upside-in-cvs-health-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412318\" data-ts=\"1543321801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCKT\" target=\"_blank\">RCKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412318-rocket-pharmaceuticals-receives-rmat-and-fast-track-designations-for-rp-l102\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rocket Pharmaceuticals receives RMAT and Fast Track designations for RP-L102</a></h4><ul> <li>The FDA has <a href=\"https://seekingalpha.com/pr/17341803-rocket-pharmaceuticals-receives-fda-regenerative-medicine-advanced-therapy-rmat-fast-track\" target=\"_blank\">granted</a> Regenerative Medicine Advanced Therapy &#40;RMAT&#41; and Fast Track designations to Rocket       Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/RCKT' title='Rocket Pharmaceuticals, Inc.'>RCKT</a>) RP-L102,       the Company\u2019s lentiviral vector-based gene therapy for the       treatment of Fanconi Anemia &#40;FA&#41;.</li>  <li>The RMAT and Fast Track designation provides for the accelerated review of the marketing application and more intensive guidance from the FDA on development.</li>                          <li>Rocket plans to initiate a clinical trial of RP-L102 for FA in early       2019 utilizing no conditioning and \u201cProcess B\u201d.</li>\n<li>Shares are up <font color=\"green\">3%</font> premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3412318\" data-linked=\"Rocket Pharmaceuticals receives RMAT and Fast Track designations for RP-L102\" data-tweet=\"$RCKT - Rocket Pharmaceuticals receives RMAT and Fast Track designations for RP-L102 https://seekingalpha.com/news/3412318-rocket-pharmaceuticals-receives-rmat-and-fast-track-designations-for-rp-l102?source=tweet\" data-url=\"https://seekingalpha.com/news/3412318-rocket-pharmaceuticals-receives-rmat-and-fast-track-designations-for-rp-l102\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412313\" data-ts=\"1543320921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412313-fda-nod-for-loxos-larotrectinib-positive-for-cancer-genetic-testing-firms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA nod for Loxo&#39;s larotrectinib a positive for cancer genetic testing firms</a></h4><ul> <li>Providers of molecular diagnostic testing services may see some action today on the heels of the FDA's approval for Loxo Oncology's VITRAKVI (larotrectinib) since it is the first cancer drug that will require prospective patients to have their DNA sequenced.</li> <li>Selected tickers: <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>, <a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a>, <a href='https://seekingalpha.com/symbol/NVTA' title='Invitae'>NVTA</a>, <a href='https://seekingalpha.com/symbol/GHDX' title='Genomic Health, Inc.'>GHDX</a>, <a href='https://seekingalpha.com/symbol/NTRA' title='Natera'>NTRA</a>, <a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a>, <a href='https://seekingalpha.com/symbol/LH' title='Laboratory Corporation of America Holdings'>LH</a></li> <li>Previously: <a href=\"https://seekingalpha.com/news/3412239-fda-oks-loxos-vitrakvi\" target=\"_blank\">FDA OKs Loxo's Vitrakvi</a> (Nov. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412313\" data-linked=\"FDA nod for Loxo&#39;s larotrectinib a positive for cancer genetic testing firms\" data-tweet=\"$BIOC $BIOC $MYGN - FDA nod for Loxo&#39;s larotrectinib a positive for cancer genetic testing firms https://seekingalpha.com/news/3412313-fda-nod-for-loxos-larotrectinib-positive-for-cancer-genetic-testing-firms?source=tweet\" data-url=\"https://seekingalpha.com/news/3412313-fda-nod-for-loxos-larotrectinib-positive-for-cancer-genetic-testing-firms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412308\" data-ts=\"1543320691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412308-apple-suppliers-mull-higher-iphone-tariffs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple suppliers mull higher iPhone tariffs</a></h4><ul> <li>Apple is <font color=\"red\">down 2%</font> premarket after the president last night <a href=\"https://seekingalpha.com/news/3412209-apple-minus-1_6-percent-trump-hints-boosted-phone-laptop-tariffs-china\" target=\"_blank\">suggested higher tariffs</a> on things like phones and laptops.</li> <li>Among suppliers on watch: Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>), NXP Semi (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>), Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>), Qorvo (NASDAQ:<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a>), Skyworks (NASDAQ:<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a>), Lumentom (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>), Taiwan Semi (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>), Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412308\" data-linked=\"Apple suppliers mull higher iPhone tariffs\" data-tweet=\"$CRUS $CRUS $NXPI - Apple suppliers mull higher iPhone tariffs https://seekingalpha.com/news/3412308-apple-suppliers-mull-higher-iphone-tariffs?source=tweet\" data-url=\"https://seekingalpha.com/news/3412308-apple-suppliers-mull-higher-iphone-tariffs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412305\" data-ts=\"1543320210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412305-canada-goose-announces-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada Goose announces share offering</a></h4><ul> <li>Canada Goose (NYSE:<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a>) announces an offering of 10M shares on the behalf of certain shareholders, including executive officers and directors.</li> <li>Bloomberg reports the offering will be priced at $65.15 per share.</li> <li>GOOS <font color=\"red\">-1.33%</font> premarket to $65.50. Canada Goose is up 110% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412305\" data-linked=\"Canada Goose announces share offering\" data-tweet=\"$GOOS - Canada Goose announces share offering https://seekingalpha.com/news/3412305-canada-goose-announces-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3412305-canada-goose-announces-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412303\" data-ts=\"1543320090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412303-bayer-prices-loxos-vitrakvi-almost-400k-per-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bayer prices Loxo&#39;s Vitrakvi at almost $400K per year</a></h4><ul> <li>Licensee Bayer (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a>), owner of global commercialization rights to Loxo Oncology's (NASDAQ:<a href='https://seekingalpha.com/symbol/LOXO' title='Loxo Oncology'>LOXO</a>) VITRAKVI (larotrectinib), has <a href=\"https://endpts.com/shattering-an-old-record-fda-oks-site-agnostic-cancer-drug-larotrectinib-from-loxo-and-bayer/\" target=\"_blank\">priced </a>the TRK inhibitor at just under $400K per year. A liquid formulation for pediatric patients will be available at $132K per annum.</li> <li>The drug breaks new ground for cancer therapies since prospective patients will need to have their DNA sequenced to determine if their cancers are TRK fusion-positive.</li> <li>Trading in LOXO, currently suspended, will resume at 7:10 am ET.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3311833-loxo-teams-bayer-develop-trk-inhibitors-shares-6-percent-premarket\" target=\"_blank\">Loxo teams up with Bayer to develop TRK inhibitors; shares up 6% premarket</a> (Nov. 14, 2017)</li>\n<li>\n<strong>Update</strong>: LOXO is up <font color=\"green\">3%</font> premarket on light volume.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3412303\" data-linked=\"Bayer prices Loxo&#39;s Vitrakvi at almost $400K per year\" data-tweet=\"$BAYRY $BAYRY $LOXO - Bayer prices Loxo&#39;s Vitrakvi at almost $400K per year https://seekingalpha.com/news/3412303-bayer-prices-loxos-vitrakvi-almost-400k-per-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3412303-bayer-prices-loxos-vitrakvi-almost-400k-per-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3412280\" data-ts=\"1543313422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3412280-seadrill-reports-9m-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill reports 9M results</a></h4><ul>\n<li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>): 9M GAAP EPS of -$10.11.</li>\n<li>Revenue of $961M (-42.1% Y/Y)</li>\n<li>Shares <font color=\"green\">+3.1%</font> PM.</li>\n<li><a href=\"https://www.seadrill.com/investors/news/pr-story.aspx?ResultPageURL=http://cws.huginonline.com/S/135817/PR/201811/2226996.xml\" target=\"_blank\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3412280\" data-linked=\"Seadrill reports 9M results\" data-tweet=\"$SDRL - Seadrill reports 9M results https://seekingalpha.com/news/3412280-seadrill-reports-9m-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3412280-seadrill-reports-9m-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}